Gene Symbol | Gene ID | Gene Info |
---|---|---|
Mef2b
|
ENSMUSG00000079033.3 | myocyte enhancer factor 2B |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr8_70150289_70150461 | Mef2b | 2403 | 0.133878 | -0.47 | 3.1e-04 | Click! |
chr8_70158695_70158876 | Mef2b | 6004 | 0.091679 | -0.34 | 1.1e-02 | Click! |
chr8_70158390_70158605 | Mef2b | 5716 | 0.092633 | -0.32 | 1.8e-02 | Click! |
chr8_70150602_70150753 | Mef2b | 2101 | 0.149362 | -0.29 | 2.9e-02 | Click! |
chr8_70152631_70152851 | Mef2b | 37 | 0.943420 | -0.23 | 9.2e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr8_122451195_122451377 | 70.65 |
Gm20735 |
predicted gene, 20735 |
1 |
0.94 |
chr2_76806390_76806720 | 67.76 |
Ttn |
titin |
19987 |
0.22 |
chr4_105100638_105100793 | 67.56 |
Prkaa2 |
protein kinase, AMP-activated, alpha 2 catalytic subunit |
9175 |
0.27 |
chr14_23243993_23244151 | 57.26 |
Gm46443 |
predicted gene, 46443 |
77072 |
0.12 |
chr3_79990611_79990765 | 56.42 |
A330069K06Rik |
RIKEN cDNA A330069K06 gene |
64204 |
0.1 |
chr15_103355478_103355629 | 54.81 |
Itga5 |
integrin alpha 5 (fibronectin receptor alpha) |
1098 |
0.34 |
chr18_61447379_61448092 | 54.76 |
Gm8755 |
predicted gene 8755 |
13534 |
0.12 |
chr11_55085489_55085675 | 53.92 |
Ccdc69 |
coiled-coil domain containing 69 |
7451 |
0.13 |
chr17_72976265_72976506 | 51.80 |
Gm23649 |
predicted gene, 23649 |
11413 |
0.22 |
chr14_66341194_66341485 | 51.58 |
Gm41183 |
predicted gene, 41183 |
110 |
0.96 |
chr17_78791164_78791351 | 51.47 |
Heatr5b |
HEAT repeat containing 5B |
4856 |
0.16 |
chr18_65395540_65395716 | 50.97 |
Alpk2 |
alpha-kinase 2 |
1562 |
0.26 |
chr14_79712973_79713133 | 50.86 |
4930452G13Rik |
RIKEN cDNA 4930452G13 gene |
9341 |
0.14 |
chr2_91117863_91118209 | 50.42 |
Mybpc3 |
myosin binding protein C, cardiac |
108 |
0.94 |
chr5_133487764_133488091 | 49.44 |
Gm10051 |
predicted pseudogene 10051 |
12804 |
0.21 |
chr11_65365869_65366034 | 48.53 |
Gm12295 |
predicted gene 12295 |
153 |
0.97 |
chr19_36264475_36264651 | 48.29 |
Gm32027 |
predicted gene, 32027 |
126 |
0.96 |
chr18_64700666_64700844 | 47.88 |
Gm50354 |
predicted gene, 50354 |
668 |
0.41 |
chr4_148667072_148667256 | 47.73 |
Gm572 |
predicted gene 572 |
23847 |
0.12 |
chr14_55003891_55004289 | 47.30 |
Myh7 |
myosin, heavy polypeptide 7, cardiac muscle, beta |
9464 |
0.07 |
chr7_128206282_128206464 | 47.25 |
Cox6a2 |
cytochrome c oxidase subunit 6A2 |
14 |
0.94 |
chr18_67327598_67327770 | 47.21 |
B430212C06Rik |
RIKEN cDNA B430212C06 gene |
287 |
0.88 |
chr13_13358201_13358384 | 46.61 |
Gpr137b |
G protein-coupled receptor 137B |
9513 |
0.11 |
chr14_55004492_55004821 | 46.38 |
Myh7 |
myosin, heavy polypeptide 7, cardiac muscle, beta |
10030 |
0.07 |
chr17_9894952_9895152 | 46.25 |
Gm49808 |
predicted gene, 49808 |
30633 |
0.15 |
chr14_55313710_55313928 | 46.19 |
Gm49022 |
predicted gene, 49022 |
33132 |
0.1 |
chr1_153280562_153280719 | 46.11 |
Gm38009 |
predicted gene, 38009 |
6550 |
0.19 |
chr13_43131939_43132171 | 46.07 |
Phactr1 |
phosphatase and actin regulator 1 |
942 |
0.57 |
chr9_67428785_67428951 | 46.07 |
Tln2 |
talin 2 |
65 |
0.98 |
chr11_83393254_83393405 | 45.30 |
Rasl10b |
RAS-like, family 10, member B |
15808 |
0.11 |
chr9_31980570_31980721 | 45.16 |
Gm47465 |
predicted gene, 47465 |
24815 |
0.13 |
chr16_59517462_59517658 | 45.10 |
Crybg3 |
beta-gamma crystallin domain containing 3 |
8054 |
0.19 |
chr15_79735486_79735674 | 44.95 |
Sun2 |
Sad1 and UNC84 domain containing 2 |
371 |
0.72 |
chr1_168476878_168477216 | 44.77 |
Mir6348 |
microRNA 6348 |
13596 |
0.25 |
chr2_173087478_173087645 | 44.60 |
Ctcflos |
CCCTC-binding factor (zinc finger protein)-like, opposite strand |
23257 |
0.13 |
chr19_53716555_53716887 | 44.60 |
Rbm20 |
RNA binding motif protein 20 |
39415 |
0.13 |
chr2_164754933_164755088 | 44.31 |
Dnttip1 |
deoxynucleotidyltransferase, terminal, interacting protein 1 |
871 |
0.34 |
chr13_42258570_42258751 | 43.72 |
Edn1 |
endothelin 1 |
42816 |
0.15 |
chr5_148272131_148272422 | 43.69 |
Mtus2 |
microtubule associated tumor suppressor candidate 2 |
6931 |
0.24 |
chrX_85731202_85731353 | 43.68 |
Gk |
glycerol kinase |
6333 |
0.16 |
chr2_77034241_77034394 | 43.62 |
Ccdc141 |
coiled-coil domain containing 141 |
3667 |
0.27 |
chr7_121111398_121111549 | 43.30 |
Otoa |
otoancorin |
6912 |
0.13 |
chr14_54996790_54997188 | 43.02 |
Myh7 |
myosin, heavy polypeptide 7, cardiac muscle, beta |
2363 |
0.11 |
chr11_76125506_76125804 | 42.88 |
Vps53 |
VPS53 GARP complex subunit |
13093 |
0.16 |
chr1_82200001_82200338 | 42.87 |
Gm9747 |
predicted gene 9747 |
32943 |
0.17 |
chr14_24575222_24575392 | 42.50 |
4930542C16Rik |
RIKEN cDNA 4930542C16 gene |
41997 |
0.13 |
chr15_84253859_84254072 | 42.42 |
Parvb |
parvin, beta |
3175 |
0.21 |
chr4_100284575_100284875 | 42.32 |
Gm12706 |
predicted gene 12706 |
77334 |
0.1 |
chr14_20664487_20664751 | 42.20 |
Synpo2l |
synaptopodin 2-like |
45 |
0.94 |
chr17_26490930_26491240 | 42.20 |
Gm34455 |
predicted gene, 34455 |
163 |
0.92 |
chr11_101842419_101842595 | 42.00 |
Gm11551 |
predicted gene 11551 |
43730 |
0.09 |
chr2_163392547_163392724 | 41.91 |
Jph2 |
junctophilin 2 |
5314 |
0.15 |
chr8_79273797_79274224 | 41.90 |
Mmaa |
methylmalonic aciduria (cobalamin deficiency) type A |
20670 |
0.14 |
chr10_24479227_24479575 | 41.79 |
Gm15271 |
predicted gene 15271 |
31911 |
0.15 |
chr1_181446826_181447104 | 41.72 |
Gm16539 |
predicted gene 16539 |
14565 |
0.18 |
chr2_114054212_114054414 | 41.64 |
C130080G10Rik |
RIKEN cDNA C130080G10 gene |
22 |
0.94 |
chr18_82791087_82791501 | 41.16 |
2210420H20Rik |
RIKEN cDNA 2210420H20 gene |
32253 |
0.1 |
chr7_68550412_68550612 | 41.11 |
Gm44887 |
predicted gene 44887 |
48342 |
0.13 |
chr2_118716801_118717058 | 40.99 |
Plcb2 |
phospholipase C, beta 2 |
2825 |
0.17 |
chr19_11969759_11969930 | 40.89 |
Osbp |
oxysterol binding protein |
3903 |
0.12 |
chr1_184171018_184171191 | 40.70 |
Dusp10 |
dual specificity phosphatase 10 |
136723 |
0.04 |
chr7_102272522_102272823 | 40.63 |
Stim1 |
stromal interaction molecule 1 |
4345 |
0.15 |
chr16_96213128_96213298 | 40.42 |
Sh3bgr |
SH3-binding domain glutamic acid-rich protein |
6570 |
0.16 |
chr11_75013749_75013922 | 40.37 |
Smg6 |
Smg-6 homolog, nonsense mediated mRNA decay factor (C. elegans) |
19982 |
0.11 |
chr4_45038101_45038392 | 40.33 |
Polr1e |
polymerase (RNA) I polypeptide E |
6984 |
0.13 |
chr13_46427501_46427664 | 40.26 |
Rbm24 |
RNA binding motif protein 24 |
5760 |
0.25 |
chr10_84230420_84230790 | 40.09 |
Gm47253 |
predicted gene, 47253 |
8548 |
0.25 |
chr14_26441437_26441768 | 39.93 |
Slmap |
sarcolemma associated protein |
1053 |
0.48 |
chr12_51907627_51907778 | 39.85 |
Heatr5a |
HEAT repeat containing 5A |
11024 |
0.21 |
chr14_21177927_21178087 | 39.65 |
Adk |
adenosine kinase |
101855 |
0.07 |
chr6_29904370_29904544 | 39.32 |
Ahcyl2 |
S-adenosylhomocysteine hydrolase-like 2 |
951 |
0.47 |
chr1_13305322_13305485 | 39.31 |
Ncoa2 |
nuclear receptor coactivator 2 |
5681 |
0.13 |
chr3_97869867_97870028 | 39.29 |
Pde4dip |
phosphodiesterase 4D interacting protein (myomegalin) |
1699 |
0.35 |
chr5_122071067_122071238 | 39.26 |
Cux2 |
cut-like homeobox 2 |
21050 |
0.12 |
chr14_10194211_10194486 | 39.11 |
Gm48439 |
predicted gene, 48439 |
15728 |
0.29 |
chr10_117042279_117042645 | 39.03 |
Gm10747 |
predicted gene 10747 |
1284 |
0.32 |
chr18_60963339_60963544 | 39.01 |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
113 |
0.95 |
chr13_93399765_93399921 | 39.01 |
Gm47155 |
predicted gene, 47155 |
10940 |
0.16 |
chr11_67798124_67798288 | 38.84 |
Dhrs7c |
dehydrogenase/reductase (SDR family) member 7C |
19 |
0.98 |
chr5_100909790_100909953 | 38.79 |
Gm36793 |
predicted gene, 36793 |
3836 |
0.19 |
chr8_45901615_45901936 | 38.78 |
Pdlim3 |
PDZ and LIM domain 3 |
13257 |
0.12 |
chr15_96059781_96059932 | 38.78 |
D030018L15Rik |
RIKEN cDNA D030018L15 gene |
5031 |
0.27 |
chr17_5997468_5997674 | 38.77 |
Synj2 |
synaptojanin 2 |
725 |
0.67 |
chr7_112660416_112660763 | 38.65 |
Gm45473 |
predicted gene 45473 |
7807 |
0.16 |
chr14_34544701_34544881 | 38.60 |
9230112D13Rik |
RIKEN cDNA 9230112D13 gene |
21990 |
0.11 |
chr2_163685720_163686065 | 38.59 |
Gm16316 |
predicted gene 16316 |
6387 |
0.15 |
chr19_46969696_46969884 | 38.59 |
Nt5c2 |
5'-nucleotidase, cytosolic II |
222 |
0.92 |
chr17_71248988_71249288 | 38.59 |
Lpin2 |
lipin 2 |
3107 |
0.21 |
chr8_95596782_95597294 | 38.58 |
Gm31518 |
predicted gene, 31518 |
3516 |
0.13 |
chr18_60458858_60459017 | 38.42 |
BC023105 |
cDNA sequence BC023105 |
17172 |
0.14 |
chr2_35994482_35994662 | 38.36 |
Ttll11 |
tubulin tyrosine ligase-like family, member 11 |
14659 |
0.17 |
chr11_108165912_108166135 | 38.32 |
Gm11655 |
predicted gene 11655 |
15827 |
0.25 |
chr3_101804311_101804830 | 38.04 |
Mab21l3 |
mab-21-like 3 |
31653 |
0.17 |
chr10_77456692_77456861 | 37.96 |
Gm35920 |
predicted gene, 35920 |
1141 |
0.45 |
chr5_135887610_135888044 | 37.89 |
Hspb1 |
heat shock protein 1 |
92 |
0.94 |
chr13_110941700_110941851 | 37.88 |
4930526H09Rik |
RIKEN cDNA 4930526H09 gene |
37929 |
0.14 |
chr13_53900736_53900939 | 37.71 |
Gm18974 |
predicted gene, 18974 |
12210 |
0.17 |
chr3_32908593_32908757 | 37.64 |
Usp13 |
ubiquitin specific peptidase 13 (isopeptidase T-3) |
6328 |
0.18 |
chr4_13157026_13157417 | 37.53 |
Gm11820 |
predicted gene 11820 |
81081 |
0.11 |
chr1_73914988_73915530 | 37.45 |
Tns1 |
tensin 1 |
12958 |
0.2 |
chr7_125753039_125753248 | 37.41 |
D430042O09Rik |
RIKEN cDNA D430042O09 gene |
33112 |
0.18 |
chr1_91350904_91351157 | 37.27 |
Klhl30 |
kelch-like 30 |
14 |
0.96 |
chr12_15594772_15594923 | 37.01 |
Gm4804 |
predicted gene 4804 |
11565 |
0.22 |
chr1_89998244_89998404 | 36.93 |
Asb18 |
ankyrin repeat and SOCS box-containing 18 |
1872 |
0.38 |
chr3_123034926_123035109 | 36.85 |
Myoz2 |
myozenin 2 |
2 |
0.97 |
chr8_107336607_107336758 | 36.78 |
Nfat5 |
nuclear factor of activated T cells 5 |
1826 |
0.36 |
chr8_41081682_41081841 | 36.77 |
Mtus1 |
mitochondrial tumor suppressor 1 |
1015 |
0.53 |
chr9_111208311_111208469 | 36.74 |
Lrrfip2 |
leucine rich repeat (in FLII) interacting protein 2 |
5803 |
0.19 |
chr3_85636982_85637133 | 36.74 |
Fam160a1 |
family with sequence similarity 160, member A1 |
36931 |
0.15 |
chr17_35549462_35549916 | 36.73 |
Cdsn |
corneodesmosin |
2439 |
0.12 |
chr13_46413709_46413871 | 36.68 |
Rbm24 |
RNA binding motif protein 24 |
4644 |
0.27 |
chr5_15966940_15967102 | 36.60 |
Gm43000 |
predicted gene 43000 |
30818 |
0.13 |
chr5_118057933_118058113 | 36.33 |
Gm9754 |
predicted gene 9754 |
7337 |
0.16 |
chr15_36855074_36855317 | 36.32 |
Gm49282 |
predicted gene, 49282 |
12379 |
0.16 |
chr14_47083955_47084113 | 36.32 |
Samd4 |
sterile alpha motif domain containing 4 |
3101 |
0.19 |
chr16_94765250_94765427 | 36.26 |
Gm41505 |
predicted gene, 41505 |
43444 |
0.14 |
chr15_101241288_101241455 | 36.12 |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
12898 |
0.09 |
chr8_11821806_11822008 | 36.04 |
Arhgef7 |
Rho guanine nucleotide exchange factor (GEF7) |
8331 |
0.14 |
chr6_17547003_17547179 | 36.02 |
Met |
met proto-oncogene |
118 |
0.97 |
chr10_63601359_63601510 | 36.02 |
Ctnna3 |
catenin (cadherin associated protein), alpha 3 |
26928 |
0.23 |
chr14_47747632_47747852 | 35.94 |
4930538L07Rik |
RIKEN cDNA 4930538L07 gene |
9744 |
0.16 |
chr10_38962295_38962446 | 35.93 |
Lama4 |
laminin, alpha 4 |
3145 |
0.3 |
chr13_32922827_32922987 | 35.88 |
Gm11382 |
predicted pseudogene 11382 |
15784 |
0.13 |
chr4_43399736_43400057 | 35.88 |
Rusc2 |
RUN and SH3 domain containing 2 |
1342 |
0.33 |
chr11_5265854_5266028 | 35.88 |
Kremen1 |
kringle containing transmembrane protein 1 |
4383 |
0.19 |
chr15_77212897_77213048 | 35.74 |
Rbfox2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
9536 |
0.16 |
chr1_186587142_186587307 | 35.65 |
A730004F24Rik |
RIKEN cDNA A730004F24 gene |
28543 |
0.18 |
chr16_4522269_4522431 | 35.62 |
Srl |
sarcalumenin |
713 |
0.62 |
chr8_125287875_125288026 | 35.57 |
Gm16237 |
predicted gene 16237 |
60627 |
0.14 |
chr8_8441699_8441850 | 35.56 |
Gm2448 |
predicted gene 2448 |
13655 |
0.17 |
chr1_50696980_50697262 | 35.56 |
Gm28321 |
predicted gene 28321 |
118254 |
0.06 |
chr18_67336367_67336539 | 35.49 |
B430212C06Rik |
RIKEN cDNA B430212C06 gene |
7130 |
0.15 |
chr1_178716472_178716623 | 35.41 |
Gm34176 |
predicted gene, 34176 |
39261 |
0.18 |
chr3_33633203_33633354 | 35.35 |
Gm5845 |
predicted gene 5845 |
11670 |
0.22 |
chr1_179606042_179606200 | 35.21 |
Cnst |
consortin, connexin sorting protein |
12731 |
0.19 |
chr9_87005459_87005701 | 35.13 |
Gm36539 |
predicted gene, 36539 |
583 |
0.73 |
chr3_105375456_105375628 | 34.99 |
Kcnd3os |
potassium voltage-gated channel, Shal-related family, member 3, opposite strand |
76185 |
0.09 |
chr13_112425406_112425587 | 34.97 |
Gm48876 |
predicted gene, 48876 |
844 |
0.53 |
chr6_120274937_120275116 | 34.97 |
B4galnt3 |
beta-1,4-N-acetyl-galactosaminyl transferase 3 |
19533 |
0.19 |
chr9_120021159_120021498 | 34.89 |
Xirp1 |
xin actin-binding repeat containing 1 |
1513 |
0.23 |
chr12_73403432_73403592 | 34.69 |
D830013O20Rik |
RIKEN cDNA D830013O20 gene |
6045 |
0.18 |
chr12_103336725_103337091 | 34.65 |
Gm15523 |
predicted gene 15523 |
2 |
0.68 |
chr8_110676672_110677057 | 34.63 |
Vac14 |
Vac14 homolog (S. cerevisiae) |
31284 |
0.14 |
chr6_51833395_51833546 | 34.55 |
Skap2 |
src family associated phosphoprotein 2 |
38459 |
0.17 |
chr2_117451999_117452164 | 34.44 |
Gm13982 |
predicted gene 13982 |
34384 |
0.21 |
chr7_81078760_81079054 | 34.33 |
Alpk3 |
alpha-kinase 3 |
15924 |
0.13 |
chr9_102511485_102511698 | 34.30 |
Ky |
kyphoscoliosis peptidase |
5841 |
0.14 |
chr10_3337632_3337959 | 34.29 |
Ppp1r14c |
protein phosphatase 1, regulatory inhibitor subunit 14C |
28262 |
0.16 |
chr10_123520733_123520884 | 34.18 |
Gm19169 |
predicted gene, 19169 |
62780 |
0.13 |
chr2_27181891_27182208 | 34.14 |
Dbh |
dopamine beta hydroxylase |
4956 |
0.13 |
chr10_17797193_17797516 | 34.03 |
Txlnb |
taxilin beta |
1098 |
0.44 |
chr13_91877371_91877615 | 34.01 |
Ckmt2 |
creatine kinase, mitochondrial 2 |
608 |
0.75 |
chr12_79905911_79906112 | 33.98 |
9430078K24Rik |
RIKEN cDNA 9430078K24 gene |
18722 |
0.2 |
chr7_48848017_48848204 | 33.98 |
Csrp3 |
cysteine and glycine-rich protein 3 |
77 |
0.96 |
chr14_27151461_27151699 | 33.96 |
Arhgef3 |
Rho guanine nucleotide exchange factor (GEF) 3 |
36681 |
0.15 |
chr6_126961470_126961621 | 33.92 |
D6Wsu163e |
DNA segment, Chr 6, Wayne State University 163, expressed |
11205 |
0.11 |
chr17_67309592_67309743 | 33.91 |
Ptprm |
protein tyrosine phosphatase, receptor type, M |
44406 |
0.2 |
chr1_160535023_160535374 | 33.82 |
Gm37212 |
predicted gene, 37212 |
38612 |
0.11 |
chr3_52983866_52984073 | 33.81 |
Cog6 |
component of oligomeric golgi complex 6 |
10716 |
0.15 |
chr2_178412652_178412870 | 33.73 |
Ppp1r3d |
protein phosphatase 1, regulatory subunit 3D |
1711 |
0.27 |
chr11_115902233_115902570 | 33.68 |
Smim5 |
small integral membrane protein 5 |
2199 |
0.15 |
chr4_139433058_139433245 | 33.64 |
Ubr4 |
ubiquitin protein ligase E3 component n-recognin 4 |
1859 |
0.31 |
chr6_29882005_29882158 | 33.56 |
Ahcyl2 |
S-adenosylhomocysteine hydrolase-like 2 |
5402 |
0.17 |
chr12_73402301_73402656 | 33.53 |
D830013O20Rik |
RIKEN cDNA D830013O20 gene |
7079 |
0.18 |
chr2_60478861_60479012 | 33.52 |
Pla2r1 |
phospholipase A2 receptor 1 |
23682 |
0.18 |
chr16_21499130_21499286 | 33.52 |
Vps8 |
VPS8 CORVET complex subunit |
9425 |
0.27 |
chr8_88334428_88334728 | 33.49 |
Brd7 |
bromodomain containing 7 |
657 |
0.72 |
chr11_67835494_67835673 | 33.45 |
Dhrs7c |
dehydrogenase/reductase (SDR family) member 7C |
37296 |
0.12 |
chr8_54886686_54886837 | 33.44 |
Wdr17 |
WD repeat domain 17 |
389 |
0.86 |
chr9_67581947_67582250 | 33.31 |
Tln2 |
talin 2 |
22395 |
0.22 |
chr5_65459587_65459763 | 33.23 |
Smim14 |
small integral membrane protein 14 |
1164 |
0.3 |
chr2_167267943_167268131 | 33.21 |
Gm11473 |
predicted gene 11473 |
13740 |
0.15 |
chr19_42238501_42238670 | 33.09 |
Golga7b |
golgi autoantigen, golgin subfamily a, 7B |
8989 |
0.13 |
chr11_31663498_31663710 | 33.07 |
Bod1 |
biorientation of chromosomes in cell division 1 |
8123 |
0.25 |
chr5_74147556_74147712 | 33.01 |
A330058E17Rik |
RIKEN cDNA A330058E17 gene |
28416 |
0.11 |
chr11_101030536_101030719 | 32.95 |
Mir6928 |
microRNA 6928 |
287 |
0.83 |
chr7_115466804_115467141 | 32.81 |
Sox6 |
SRY (sex determining region Y)-box 6 |
130924 |
0.05 |
chr1_62992787_62992946 | 32.78 |
Gm44468 |
predicted gene, 44468 |
32876 |
0.12 |
chr15_58324072_58324603 | 32.77 |
Klhl38 |
kelch-like 38 |
168 |
0.96 |
chr10_5068666_5068841 | 32.72 |
Syne1 |
spectrin repeat containing, nuclear envelope 1 |
160 |
0.79 |
chr16_54354555_54354714 | 32.63 |
Gm25853 |
predicted gene, 25853 |
172 |
0.96 |
chr5_55049390_55049541 | 32.56 |
Gm43779 |
predicted gene 43779 |
52845 |
0.18 |
chr17_56740210_56740419 | 32.55 |
Fut4-ps1 |
fucosyltransferase 4, pseudogene 1 |
1982 |
0.18 |
chr3_40453568_40453719 | 32.52 |
1700017G19Rik |
RIKEN cDNA 1700017G19 gene |
56131 |
0.13 |
chr9_102497922_102498082 | 32.52 |
Ky |
kyphoscoliosis peptidase |
7748 |
0.14 |
chr2_77182419_77182600 | 32.51 |
Ccdc141 |
coiled-coil domain containing 141 |
11873 |
0.2 |
chr10_95970760_95970911 | 32.49 |
Eea1 |
early endosome antigen 1 |
30078 |
0.15 |
chr1_40805490_40805643 | 32.47 |
Tmem182 |
transmembrane protein 182 |
35 |
0.97 |
chr8_11334571_11334742 | 32.45 |
Col4a1 |
collagen, type IV, alpha 1 |
21830 |
0.14 |
chr11_90255756_90255960 | 32.40 |
Mmd |
monocyte to macrophage differentiation-associated |
6382 |
0.23 |
chr12_90946629_90946791 | 32.14 |
Gm47688 |
predicted gene, 47688 |
8328 |
0.18 |
chr3_102099338_102099510 | 32.07 |
Casq2 |
calsequestrin 2 |
12785 |
0.13 |
chr9_46196757_46196923 | 32.03 |
Sik3 |
SIK family kinase 3 |
22731 |
0.1 |
chr6_14755283_14755434 | 31.90 |
Ppp1r3a |
protein phosphatase 1, regulatory subunit 3A |
84 |
0.99 |
chr16_78275254_78275407 | 31.81 |
E330011O21Rik |
RIKEN cDNA E330011O21 gene |
52 |
0.97 |
chr5_36367190_36367350 | 31.80 |
Sorcs2 |
sortilin-related VPS10 domain containing receptor 2 |
1352 |
0.48 |
chr19_37315169_37315320 | 31.79 |
Ide |
insulin degrading enzyme |
1671 |
0.32 |
chr4_14747582_14747758 | 31.79 |
Lrrc69 |
leucine rich repeat containing 69 |
9175 |
0.22 |
chr11_98394434_98394800 | 31.65 |
Pgap3 |
post-GPI attachment to proteins 3 |
2545 |
0.12 |
chr13_59624965_59625118 | 31.60 |
Naa35 |
N(alpha)-acetyltransferase 35, NatC auxiliary subunit |
597 |
0.64 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
28.1 | 112.3 | GO:0035995 | detection of muscle stretch(GO:0035995) |
19.1 | 57.2 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
15.4 | 46.1 | GO:0031034 | myosin filament assembly(GO:0031034) |
13.4 | 26.8 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
12.1 | 24.1 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
10.8 | 32.5 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
10.4 | 51.8 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
9.9 | 29.8 | GO:0030421 | defecation(GO:0030421) |
9.2 | 27.5 | GO:1990928 | response to amino acid starvation(GO:1990928) |
9.1 | 27.2 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
9.0 | 36.1 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
8.9 | 26.8 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
8.9 | 26.8 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
8.6 | 51.8 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
8.2 | 8.2 | GO:0038179 | neurotrophin signaling pathway(GO:0038179) |
7.8 | 31.3 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
7.2 | 50.4 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
6.8 | 13.7 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
6.7 | 33.4 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
6.5 | 32.7 | GO:0003192 | mitral valve formation(GO:0003192) |
6.4 | 19.2 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
6.2 | 24.9 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
6.1 | 12.2 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
6.0 | 54.0 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
5.9 | 11.8 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
5.9 | 29.4 | GO:0071476 | cellular hypotonic response(GO:0071476) |
5.7 | 34.4 | GO:0090527 | actin filament reorganization(GO:0090527) |
5.7 | 17.1 | GO:0007525 | somatic muscle development(GO:0007525) |
5.7 | 11.4 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
5.6 | 39.0 | GO:0001778 | plasma membrane repair(GO:0001778) |
5.5 | 21.8 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
5.4 | 16.1 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
5.3 | 21.1 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
5.2 | 5.2 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
5.2 | 26.0 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
5.1 | 41.0 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
5.1 | 20.4 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
5.0 | 10.0 | GO:1904193 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
5.0 | 14.9 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
4.8 | 14.4 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
4.7 | 47.4 | GO:0046085 | adenosine metabolic process(GO:0046085) |
4.7 | 65.9 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
4.5 | 22.5 | GO:1904424 | regulation of GTP binding(GO:1904424) |
4.4 | 13.2 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
4.3 | 13.0 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
4.3 | 29.9 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
4.2 | 21.2 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
4.2 | 21.1 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
4.2 | 29.1 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
4.1 | 37.3 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
4.1 | 41.3 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
4.1 | 8.3 | GO:0048370 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
4.1 | 24.7 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
4.1 | 12.2 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
3.9 | 59.0 | GO:0014850 | response to muscle activity(GO:0014850) |
3.9 | 35.2 | GO:0030049 | muscle filament sliding(GO:0030049) |
3.9 | 7.8 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
3.8 | 3.8 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
3.7 | 14.8 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
3.7 | 3.7 | GO:0070350 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
3.7 | 11.1 | GO:0034727 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
3.7 | 44.1 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
3.6 | 3.6 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
3.5 | 10.6 | GO:0001757 | somite specification(GO:0001757) |
3.5 | 10.4 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
3.4 | 24.1 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
3.4 | 10.3 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
3.4 | 6.8 | GO:0032439 | endosome localization(GO:0032439) |
3.4 | 16.9 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
3.4 | 3.4 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
3.4 | 20.2 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
3.3 | 16.7 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
3.3 | 6.6 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
3.3 | 22.9 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
3.3 | 19.6 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
3.2 | 6.4 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
3.2 | 9.6 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
3.2 | 9.6 | GO:0021564 | vagus nerve development(GO:0021564) |
3.2 | 9.5 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
3.2 | 15.8 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
3.1 | 22.0 | GO:0042118 | endothelial cell activation(GO:0042118) |
3.1 | 24.9 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
3.1 | 9.2 | GO:0060486 | Clara cell differentiation(GO:0060486) |
3.0 | 6.1 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
3.0 | 6.0 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
3.0 | 21.1 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
3.0 | 12.0 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
3.0 | 9.0 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
3.0 | 3.0 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
3.0 | 11.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
3.0 | 5.9 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
2.9 | 8.8 | GO:0006533 | aspartate catabolic process(GO:0006533) |
2.9 | 11.6 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
2.9 | 8.6 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
2.8 | 8.5 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
2.8 | 42.2 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
2.8 | 2.8 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
2.7 | 8.2 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
2.7 | 8.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
2.7 | 10.8 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
2.7 | 40.4 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
2.7 | 8.1 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
2.7 | 16.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
2.7 | 5.3 | GO:0060591 | chondroblast differentiation(GO:0060591) |
2.6 | 15.7 | GO:0051255 | spindle midzone assembly(GO:0051255) |
2.6 | 2.6 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
2.6 | 7.8 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
2.6 | 67.7 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
2.6 | 10.3 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
2.6 | 7.8 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
2.6 | 10.3 | GO:0042420 | dopamine catabolic process(GO:0042420) |
2.6 | 7.7 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
2.6 | 7.7 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
2.5 | 7.6 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
2.5 | 7.5 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
2.5 | 17.4 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
2.5 | 14.9 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
2.5 | 7.4 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
2.5 | 7.4 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
2.5 | 12.3 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
2.5 | 7.4 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
2.5 | 7.4 | GO:0071492 | cellular response to UV-A(GO:0071492) |
2.5 | 9.8 | GO:0007296 | vitellogenesis(GO:0007296) |
2.5 | 56.4 | GO:0045214 | sarcomere organization(GO:0045214) |
2.4 | 7.3 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
2.4 | 7.3 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
2.4 | 19.4 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
2.4 | 7.2 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
2.4 | 9.6 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
2.4 | 2.4 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
2.4 | 9.4 | GO:0003383 | apical constriction(GO:0003383) |
2.3 | 7.0 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
2.3 | 7.0 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
2.3 | 37.4 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
2.3 | 7.0 | GO:0007403 | glial cell fate determination(GO:0007403) |
2.3 | 16.1 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
2.3 | 23.0 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
2.3 | 25.2 | GO:0001553 | luteinization(GO:0001553) |
2.3 | 2.3 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
2.3 | 16.0 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
2.3 | 6.8 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
2.3 | 4.6 | GO:2001212 | regulation of vasculogenesis(GO:2001212) |
2.3 | 4.5 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
2.2 | 8.9 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
2.2 | 8.8 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
2.2 | 13.2 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
2.2 | 4.4 | GO:0010692 | regulation of alkaline phosphatase activity(GO:0010692) |
2.2 | 4.4 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
2.2 | 4.4 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
2.2 | 8.7 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
2.2 | 6.5 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
2.2 | 10.8 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
2.2 | 2.2 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
2.1 | 10.7 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
2.1 | 6.4 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
2.1 | 6.4 | GO:1904304 | regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) |
2.1 | 37.9 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
2.1 | 6.3 | GO:0060618 | nipple development(GO:0060618) |
2.1 | 6.3 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
2.1 | 8.3 | GO:0019230 | proprioception(GO:0019230) |
2.1 | 37.3 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
2.1 | 2.1 | GO:0014904 | myotube cell development(GO:0014904) |
2.1 | 6.2 | GO:0072092 | ureteric bud invasion(GO:0072092) |
2.1 | 26.7 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
2.1 | 8.2 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
2.0 | 20.4 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
2.0 | 10.2 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
2.0 | 4.0 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
2.0 | 4.0 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
2.0 | 6.0 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
2.0 | 13.8 | GO:0030239 | myofibril assembly(GO:0030239) |
2.0 | 5.9 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
2.0 | 15.7 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
2.0 | 7.8 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
1.9 | 7.8 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
1.9 | 5.8 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
1.9 | 5.8 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
1.9 | 5.7 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
1.9 | 19.1 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
1.9 | 7.5 | GO:0051031 | tRNA transport(GO:0051031) |
1.9 | 3.7 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
1.8 | 5.5 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
1.8 | 1.8 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
1.8 | 5.5 | GO:0006624 | vacuolar protein processing(GO:0006624) |
1.8 | 7.3 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
1.8 | 1.8 | GO:0072144 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
1.8 | 5.5 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
1.8 | 5.4 | GO:0042045 | epithelial fluid transport(GO:0042045) |
1.8 | 16.1 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
1.8 | 5.4 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
1.8 | 10.7 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
1.8 | 5.3 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
1.8 | 22.9 | GO:0030325 | adrenal gland development(GO:0030325) |
1.7 | 7.0 | GO:0042504 | tyrosine phosphorylation of Stat4 protein(GO:0042504) regulation of tyrosine phosphorylation of Stat4 protein(GO:0042519) |
1.7 | 10.4 | GO:0090237 | regulation of arachidonic acid secretion(GO:0090237) |
1.7 | 20.9 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
1.7 | 1.7 | GO:0010958 | regulation of amino acid import(GO:0010958) |
1.7 | 6.9 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
1.7 | 1.7 | GO:0046449 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
1.7 | 5.2 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
1.7 | 5.2 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
1.7 | 5.2 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
1.7 | 3.4 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
1.7 | 8.5 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
1.7 | 30.7 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
1.7 | 3.4 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
1.7 | 5.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
1.7 | 5.1 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
1.7 | 3.4 | GO:0030222 | eosinophil differentiation(GO:0030222) |
1.7 | 1.7 | GO:0060405 | regulation of penile erection(GO:0060405) positive regulation of penile erection(GO:0060406) |
1.7 | 18.3 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) positive regulation of glycogen metabolic process(GO:0070875) |
1.7 | 3.3 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
1.7 | 3.3 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
1.6 | 3.3 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
1.6 | 4.9 | GO:0033121 | regulation of purine nucleotide catabolic process(GO:0033121) negative regulation of purine nucleotide catabolic process(GO:0033122) |
1.6 | 6.6 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
1.6 | 6.5 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
1.6 | 1.6 | GO:1903416 | response to glycoside(GO:1903416) |
1.6 | 4.9 | GO:0007208 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) |
1.6 | 4.9 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
1.6 | 4.9 | GO:1902219 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
1.6 | 6.5 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
1.6 | 6.5 | GO:2000618 | regulation of histone H4-K16 acetylation(GO:2000618) |
1.6 | 8.0 | GO:0005513 | detection of calcium ion(GO:0005513) |
1.6 | 3.2 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
1.6 | 1.6 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
1.6 | 1.6 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
1.6 | 12.7 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
1.6 | 1.6 | GO:0021559 | trigeminal nerve development(GO:0021559) |
1.6 | 3.1 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
1.6 | 1.6 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
1.6 | 10.9 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
1.6 | 4.7 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
1.6 | 57.7 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
1.6 | 3.1 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
1.5 | 4.6 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
1.5 | 7.7 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.5 | 3.1 | GO:0072106 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
1.5 | 4.6 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
1.5 | 3.1 | GO:0071868 | cellular response to monoamine stimulus(GO:0071868) |
1.5 | 12.1 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
1.5 | 7.6 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
1.5 | 6.0 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
1.5 | 3.0 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
1.5 | 12.0 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
1.5 | 7.5 | GO:1904417 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
1.5 | 3.0 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
1.5 | 3.0 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
1.5 | 4.5 | GO:0006768 | biotin metabolic process(GO:0006768) |
1.5 | 3.0 | GO:0061055 | myotome development(GO:0061055) |
1.5 | 8.9 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
1.5 | 1.5 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
1.5 | 7.4 | GO:0072675 | osteoclast fusion(GO:0072675) |
1.5 | 11.7 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
1.5 | 1.5 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
1.5 | 1.5 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
1.5 | 8.7 | GO:0051013 | microtubule severing(GO:0051013) |
1.4 | 1.4 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
1.4 | 1.4 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
1.4 | 5.8 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
1.4 | 7.2 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) |
1.4 | 7.1 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
1.4 | 8.5 | GO:0006907 | pinocytosis(GO:0006907) |
1.4 | 1.4 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
1.4 | 1.4 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
1.4 | 19.6 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
1.4 | 2.8 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.4 | 8.4 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
1.4 | 4.2 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
1.4 | 33.3 | GO:0006270 | DNA replication initiation(GO:0006270) |
1.4 | 8.3 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
1.4 | 23.5 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
1.4 | 1.4 | GO:1902003 | regulation of beta-amyloid formation(GO:1902003) |
1.4 | 6.9 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
1.4 | 5.5 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
1.4 | 1.4 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
1.4 | 5.5 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
1.4 | 4.1 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
1.4 | 1.4 | GO:1901888 | regulation of cell junction assembly(GO:1901888) |
1.4 | 2.7 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
1.4 | 4.1 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
1.4 | 2.7 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
1.3 | 8.1 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
1.3 | 18.9 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
1.3 | 1.3 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
1.3 | 6.7 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
1.3 | 4.0 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
1.3 | 4.0 | GO:0055119 | relaxation of cardiac muscle(GO:0055119) |
1.3 | 16.0 | GO:0015858 | nucleoside transport(GO:0015858) |
1.3 | 9.3 | GO:0045176 | apical protein localization(GO:0045176) |
1.3 | 1.3 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
1.3 | 6.6 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
1.3 | 5.3 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
1.3 | 5.3 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
1.3 | 2.6 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
1.3 | 5.3 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
1.3 | 2.6 | GO:0003093 | regulation of glomerular filtration(GO:0003093) |
1.3 | 6.6 | GO:0071763 | nuclear membrane organization(GO:0071763) |
1.3 | 39.5 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
1.3 | 2.6 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
1.3 | 1.3 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
1.3 | 3.9 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
1.3 | 3.9 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
1.3 | 3.9 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.3 | 7.8 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
1.3 | 7.8 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
1.3 | 13.0 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
1.3 | 3.9 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
1.3 | 5.2 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
1.3 | 1.3 | GO:0072093 | metanephric renal vesicle formation(GO:0072093) |
1.3 | 16.7 | GO:0055001 | muscle cell development(GO:0055001) |
1.3 | 7.7 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
1.3 | 2.6 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
1.3 | 19.2 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
1.3 | 2.5 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
1.3 | 1.3 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
1.3 | 5.0 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
1.3 | 5.0 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
1.3 | 3.8 | GO:0023021 | termination of signal transduction(GO:0023021) |
1.3 | 1.3 | GO:0072173 | metanephric tubule morphogenesis(GO:0072173) |
1.2 | 5.0 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
1.2 | 7.5 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
1.2 | 8.7 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
1.2 | 2.5 | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) |
1.2 | 13.6 | GO:0006376 | mRNA splice site selection(GO:0006376) |
1.2 | 5.0 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
1.2 | 2.5 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
1.2 | 3.7 | GO:0015755 | fructose transport(GO:0015755) |
1.2 | 1.2 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
1.2 | 6.1 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
1.2 | 3.7 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
1.2 | 30.6 | GO:0043149 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
1.2 | 4.9 | GO:0044351 | macropinocytosis(GO:0044351) |
1.2 | 8.5 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
1.2 | 11.0 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
1.2 | 8.5 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
1.2 | 2.4 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
1.2 | 1.2 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
1.2 | 4.9 | GO:0051138 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
1.2 | 25.5 | GO:0045109 | intermediate filament organization(GO:0045109) |
1.2 | 2.4 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
1.2 | 2.4 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
1.2 | 7.2 | GO:0015074 | DNA integration(GO:0015074) |
1.2 | 3.6 | GO:0006591 | ornithine metabolic process(GO:0006591) |
1.2 | 1.2 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
1.2 | 1.2 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
1.2 | 6.0 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
1.2 | 7.1 | GO:0006527 | arginine catabolic process(GO:0006527) |
1.2 | 5.9 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.2 | 1.2 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
1.2 | 4.7 | GO:0030578 | PML body organization(GO:0030578) |
1.2 | 4.7 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
1.2 | 1.2 | GO:2000794 | regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
1.2 | 2.3 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
1.2 | 8.2 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
1.2 | 37.3 | GO:0030032 | lamellipodium assembly(GO:0030032) |
1.2 | 3.5 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
1.2 | 1.2 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
1.2 | 3.5 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
1.2 | 17.3 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
1.2 | 16.1 | GO:0045475 | locomotor rhythm(GO:0045475) |
1.1 | 29.9 | GO:0007528 | neuromuscular junction development(GO:0007528) |
1.1 | 8.0 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
1.1 | 3.4 | GO:0031099 | regeneration(GO:0031099) |
1.1 | 19.3 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
1.1 | 5.7 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
1.1 | 1.1 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
1.1 | 5.7 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
1.1 | 2.3 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
1.1 | 12.4 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
1.1 | 2.3 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
1.1 | 4.5 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
1.1 | 3.4 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
1.1 | 7.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
1.1 | 3.4 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
1.1 | 2.2 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
1.1 | 2.2 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
1.1 | 2.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
1.1 | 6.7 | GO:0050802 | regulation of circadian sleep/wake cycle, sleep(GO:0045187) circadian sleep/wake cycle, sleep(GO:0050802) |
1.1 | 4.4 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
1.1 | 5.5 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
1.1 | 3.3 | GO:0046208 | spermine catabolic process(GO:0046208) |
1.1 | 2.2 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
1.1 | 2.2 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
1.1 | 5.5 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
1.1 | 4.4 | GO:0042637 | catagen(GO:0042637) |
1.1 | 2.2 | GO:0034443 | regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) |
1.1 | 23.0 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
1.1 | 1.1 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
1.1 | 8.8 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
1.1 | 7.6 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
1.1 | 13.1 | GO:0045103 | intermediate filament-based process(GO:0045103) |
1.1 | 3.3 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
1.1 | 1.1 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
1.1 | 1.1 | GO:0006868 | glutamine transport(GO:0006868) |
1.1 | 6.5 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
1.1 | 2.2 | GO:0050904 | diapedesis(GO:0050904) |
1.1 | 6.5 | GO:0043589 | skin morphogenesis(GO:0043589) |
1.1 | 4.3 | GO:0010744 | positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
1.1 | 18.3 | GO:1900015 | regulation of cytokine production involved in inflammatory response(GO:1900015) |
1.1 | 2.1 | GO:2000391 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
1.1 | 1.1 | GO:0002576 | platelet degranulation(GO:0002576) |
1.1 | 7.5 | GO:0046069 | cGMP catabolic process(GO:0046069) |
1.1 | 1.1 | GO:0008078 | mesodermal cell migration(GO:0008078) |
1.1 | 12.8 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
1.1 | 1.1 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
1.1 | 1.1 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
1.1 | 3.2 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
1.1 | 7.4 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
1.1 | 3.2 | GO:0031946 | negative regulation of glucocorticoid metabolic process(GO:0031944) regulation of glucocorticoid biosynthetic process(GO:0031946) negative regulation of glucocorticoid biosynthetic process(GO:0031947) negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) regulation of cortisol biosynthetic process(GO:2000064) negative regulation of cortisol biosynthetic process(GO:2000065) |
1.1 | 1.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
1.1 | 25.3 | GO:0021799 | cerebral cortex radially oriented cell migration(GO:0021799) |
1.1 | 3.2 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
1.1 | 4.2 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
1.1 | 2.1 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
1.1 | 3.2 | GO:0001927 | exocyst assembly(GO:0001927) |
1.1 | 24.2 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
1.0 | 8.4 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
1.0 | 2.1 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
1.0 | 8.3 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
1.0 | 4.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
1.0 | 7.2 | GO:0035493 | SNARE complex assembly(GO:0035493) |
1.0 | 11.3 | GO:0042407 | cristae formation(GO:0042407) |
1.0 | 7.2 | GO:0035813 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
1.0 | 31.8 | GO:0009268 | response to pH(GO:0009268) |
1.0 | 7.2 | GO:0010543 | regulation of platelet activation(GO:0010543) |
1.0 | 2.0 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
1.0 | 13.3 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
1.0 | 1.0 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
1.0 | 4.1 | GO:0090168 | Golgi reassembly(GO:0090168) |
1.0 | 61.4 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
1.0 | 4.0 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
1.0 | 2.0 | GO:0046061 | dATP catabolic process(GO:0046061) |
1.0 | 1.0 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
1.0 | 13.0 | GO:0009299 | mRNA transcription(GO:0009299) |
1.0 | 14.0 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
1.0 | 8.0 | GO:0008090 | retrograde axonal transport(GO:0008090) |
1.0 | 3.0 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
1.0 | 2.0 | GO:0001945 | lymph vessel development(GO:0001945) |
1.0 | 7.0 | GO:0006857 | oligopeptide transport(GO:0006857) |
1.0 | 5.0 | GO:0070431 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
1.0 | 4.0 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
1.0 | 3.0 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
1.0 | 1.0 | GO:0003321 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
1.0 | 1.0 | GO:0009169 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
1.0 | 5.9 | GO:0043217 | myelin maintenance(GO:0043217) |
1.0 | 4.9 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
1.0 | 5.9 | GO:0015670 | carbon dioxide transport(GO:0015670) |
1.0 | 2.9 | GO:0061084 | negative regulation of protein refolding(GO:0061084) |
1.0 | 5.9 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
1.0 | 3.9 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
1.0 | 2.0 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
1.0 | 5.9 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
1.0 | 3.9 | GO:0036089 | cleavage furrow formation(GO:0036089) |
1.0 | 5.9 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
1.0 | 5.8 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
1.0 | 1.9 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
1.0 | 1.0 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
1.0 | 14.5 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
1.0 | 5.8 | GO:1904406 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
1.0 | 2.9 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) negative regulation of neurotransmitter transport(GO:0051589) |
1.0 | 1.9 | GO:0006642 | triglyceride mobilization(GO:0006642) |
1.0 | 32.5 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
1.0 | 3.8 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
1.0 | 2.9 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.9 | 3.8 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.9 | 5.7 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.9 | 3.8 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
0.9 | 32.0 | GO:0045445 | myoblast differentiation(GO:0045445) |
0.9 | 1.9 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.9 | 2.8 | GO:0000237 | leptotene(GO:0000237) |
0.9 | 9.3 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.9 | 3.7 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.9 | 1.9 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.9 | 8.3 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.9 | 2.7 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.9 | 1.8 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.9 | 0.9 | GO:0060231 | mesenchymal to epithelial transition(GO:0060231) |
0.9 | 88.3 | GO:0006936 | muscle contraction(GO:0006936) |
0.9 | 3.6 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.9 | 1.8 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.9 | 1.8 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.9 | 29.8 | GO:0044042 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.9 | 1.8 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.9 | 3.6 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.9 | 10.7 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.9 | 8.9 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.9 | 3.6 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.9 | 1.8 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
0.9 | 4.4 | GO:0016322 | neuron remodeling(GO:0016322) |
0.9 | 15.0 | GO:0003012 | muscle system process(GO:0003012) |
0.9 | 7.9 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.9 | 2.6 | GO:0030070 | insulin processing(GO:0030070) |
0.9 | 0.9 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.9 | 0.9 | GO:0072679 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.9 | 1.7 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.9 | 2.6 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.9 | 4.3 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
0.9 | 79.3 | GO:0007519 | skeletal muscle tissue development(GO:0007519) |
0.9 | 6.0 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.9 | 2.6 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) |
0.9 | 6.9 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.9 | 1.7 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.9 | 0.9 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.9 | 0.9 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.9 | 1.7 | GO:1904747 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.9 | 1.7 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.8 | 2.5 | GO:0070572 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.8 | 0.8 | GO:0071605 | monocyte chemotactic protein-1 production(GO:0071605) regulation of monocyte chemotactic protein-1 production(GO:0071637) |
0.8 | 0.8 | GO:0046049 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.8 | 0.8 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.8 | 1.7 | GO:0042023 | DNA endoreduplication(GO:0042023) |
0.8 | 3.3 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.8 | 0.8 | GO:0035625 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.8 | 3.3 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.8 | 4.9 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.8 | 2.5 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.8 | 0.8 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.8 | 1.6 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.8 | 33.4 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.8 | 25.2 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.8 | 3.2 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.8 | 4.1 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.8 | 10.6 | GO:0051291 | protein heterooligomerization(GO:0051291) |
0.8 | 0.8 | GO:0097484 | dendrite extension(GO:0097484) |
0.8 | 6.5 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.8 | 2.4 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.8 | 0.8 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.8 | 6.4 | GO:0031100 | organ regeneration(GO:0031100) |
0.8 | 1.6 | GO:0035627 | ceramide transport(GO:0035627) |
0.8 | 31.2 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.8 | 4.8 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.8 | 1.6 | GO:0097264 | self proteolysis(GO:0097264) |
0.8 | 1.6 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.8 | 1.6 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
0.8 | 4.7 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.8 | 3.1 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
0.8 | 3.1 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.8 | 0.8 | GO:0015819 | lysine transport(GO:0015819) |
0.8 | 2.3 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.8 | 3.1 | GO:1900225 | regulation of NLRP3 inflammasome complex assembly(GO:1900225) |
0.8 | 2.3 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.8 | 3.9 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.8 | 0.8 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.8 | 15.4 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.8 | 3.1 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.8 | 6.1 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.8 | 3.1 | GO:0060068 | vagina development(GO:0060068) |
0.8 | 0.8 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.8 | 4.6 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.8 | 3.0 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.8 | 2.3 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.8 | 3.8 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.8 | 4.5 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.8 | 3.8 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.8 | 5.3 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.7 | 2.2 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.7 | 5.2 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) |
0.7 | 3.7 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.7 | 3.0 | GO:0042640 | anagen(GO:0042640) |
0.7 | 3.0 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.7 | 27.5 | GO:0032024 | positive regulation of insulin secretion(GO:0032024) |
0.7 | 1.5 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.7 | 9.6 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.7 | 1.5 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.7 | 6.6 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.7 | 2.2 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.7 | 2.9 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.7 | 4.4 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.7 | 2.2 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.7 | 10.2 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.7 | 2.2 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.7 | 3.6 | GO:0042506 | tyrosine phosphorylation of Stat5 protein(GO:0042506) |
0.7 | 1.4 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.7 | 2.2 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.7 | 1.4 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.7 | 2.2 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.7 | 1.4 | GO:0033604 | negative regulation of catecholamine secretion(GO:0033604) |
0.7 | 0.7 | GO:0071649 | regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
0.7 | 2.9 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.7 | 3.6 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.7 | 5.8 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.7 | 2.2 | GO:0072606 | interleukin-8 secretion(GO:0072606) |
0.7 | 2.1 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.7 | 1.4 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.7 | 1.4 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.7 | 2.1 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.7 | 2.1 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.7 | 9.9 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.7 | 4.3 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.7 | 2.1 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.7 | 2.1 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.7 | 0.7 | GO:0010634 | positive regulation of epithelial cell migration(GO:0010634) |
0.7 | 2.1 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.7 | 2.1 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.7 | 16.7 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.7 | 2.8 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.7 | 2.8 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.7 | 20.1 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.7 | 5.5 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.7 | 4.1 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.7 | 2.1 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.7 | 3.4 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.7 | 6.2 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.7 | 2.7 | GO:0006983 | ER overload response(GO:0006983) |
0.7 | 1.4 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.7 | 0.7 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.7 | 2.7 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.7 | 12.2 | GO:0060325 | face morphogenesis(GO:0060325) |
0.7 | 6.1 | GO:0060043 | regulation of cardiac muscle cell proliferation(GO:0060043) |
0.7 | 3.4 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.7 | 6.1 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.7 | 2.7 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.7 | 2.7 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.7 | 18.9 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.7 | 1.3 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.7 | 22.8 | GO:0007041 | lysosomal transport(GO:0007041) |
0.7 | 2.0 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.7 | 2.0 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.7 | 2.7 | GO:0001842 | neural fold formation(GO:0001842) |
0.7 | 4.0 | GO:0032328 | alanine transport(GO:0032328) |
0.7 | 2.0 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.7 | 0.7 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.7 | 4.0 | GO:0007097 | nuclear migration(GO:0007097) |
0.7 | 0.7 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.7 | 2.0 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.7 | 1.3 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.7 | 0.7 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.7 | 4.6 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.7 | 2.0 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.7 | 1.3 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.7 | 1.3 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.7 | 0.7 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.6 | 1.3 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.6 | 3.9 | GO:0043304 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.6 | 4.5 | GO:0044126 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.6 | 2.6 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.6 | 0.6 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.6 | 3.2 | GO:0001946 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.6 | 1.9 | GO:0015888 | thiamine transport(GO:0015888) |
0.6 | 3.2 | GO:1902116 | negative regulation of organelle assembly(GO:1902116) |
0.6 | 4.5 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.6 | 3.9 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.6 | 1.9 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.6 | 35.2 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.6 | 4.5 | GO:0051601 | exocyst localization(GO:0051601) |
0.6 | 1.9 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.6 | 1.9 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.6 | 3.8 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
0.6 | 1.3 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
0.6 | 1.3 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.6 | 1.3 | GO:0032885 | regulation of polysaccharide biosynthetic process(GO:0032885) |
0.6 | 1.9 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.6 | 0.6 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.6 | 2.5 | GO:0051155 | positive regulation of striated muscle cell differentiation(GO:0051155) |
0.6 | 1.9 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.6 | 4.4 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.6 | 0.6 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.6 | 1.2 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.6 | 8.0 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.6 | 3.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.6 | 1.2 | GO:0046931 | pore complex assembly(GO:0046931) |
0.6 | 1.2 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.6 | 1.2 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.6 | 1.8 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
0.6 | 0.6 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.6 | 3.0 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.6 | 12.8 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.6 | 1.2 | GO:1902075 | cellular response to salt(GO:1902075) |
0.6 | 2.4 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.6 | 0.6 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.6 | 1.2 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.6 | 0.6 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.6 | 3.6 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.6 | 1.8 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.6 | 7.8 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.6 | 1.8 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.6 | 0.6 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.6 | 7.1 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.6 | 1.8 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.6 | 1.8 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.6 | 0.6 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.6 | 4.7 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.6 | 1.8 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.6 | 2.3 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.6 | 8.8 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.6 | 0.6 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.6 | 1.2 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.6 | 11.7 | GO:0019835 | cytolysis(GO:0019835) |
0.6 | 32.7 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.6 | 7.6 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.6 | 1.2 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.6 | 11.1 | GO:0006301 | postreplication repair(GO:0006301) |
0.6 | 0.6 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.6 | 1.7 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.6 | 1.2 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.6 | 0.6 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.6 | 0.6 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.6 | 1.7 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.6 | 4.6 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.6 | 1.7 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.6 | 2.3 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.6 | 10.9 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.6 | 4.6 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.6 | 4.6 | GO:0001675 | acrosome assembly(GO:0001675) |
0.6 | 5.1 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.6 | 0.6 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.6 | 2.3 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.6 | 0.6 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.6 | 1.1 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.6 | 0.6 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.6 | 8.5 | GO:0048286 | lung alveolus development(GO:0048286) |
0.6 | 1.1 | GO:0032816 | positive regulation of natural killer cell activation(GO:0032816) |
0.6 | 3.4 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.6 | 2.2 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.6 | 1.1 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.6 | 1.1 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.6 | 0.6 | GO:0014823 | response to activity(GO:0014823) |
0.6 | 0.6 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.5 | 0.5 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.5 | 9.9 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.5 | 4.3 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.5 | 1.1 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.5 | 0.5 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.5 | 1.6 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.5 | 0.5 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.5 | 0.5 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.5 | 20.4 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.5 | 5.9 | GO:0034340 | response to type I interferon(GO:0034340) |
0.5 | 0.5 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.5 | 2.1 | GO:0030091 | protein repair(GO:0030091) |
0.5 | 4.3 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.5 | 0.5 | GO:0032799 | low-density lipoprotein receptor particle metabolic process(GO:0032799) |
0.5 | 5.9 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.5 | 2.7 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.5 | 8.5 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.5 | 2.1 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.5 | 0.5 | GO:0042525 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.5 | 1.6 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.5 | 2.1 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.5 | 1.6 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.5 | 0.5 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.5 | 0.5 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.5 | 2.1 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.5 | 0.5 | GO:1902991 | regulation of amyloid precursor protein catabolic process(GO:1902991) |
0.5 | 1.6 | GO:0090656 | t-circle formation(GO:0090656) |
0.5 | 0.5 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
0.5 | 1.0 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.5 | 5.2 | GO:0007588 | excretion(GO:0007588) |
0.5 | 1.0 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.5 | 4.7 | GO:0030816 | positive regulation of cAMP metabolic process(GO:0030816) |
0.5 | 2.1 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
0.5 | 4.1 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.5 | 4.1 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.5 | 1.0 | GO:0060600 | dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
0.5 | 4.7 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.5 | 0.5 | GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) |
0.5 | 4.1 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.5 | 1.0 | GO:0016264 | gap junction assembly(GO:0016264) |
0.5 | 0.5 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.5 | 3.6 | GO:0015816 | glycine transport(GO:0015816) |
0.5 | 0.5 | GO:0090032 | negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.5 | 1.5 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.5 | 3.1 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.5 | 2.0 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.5 | 1.5 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.5 | 1.0 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.5 | 1.5 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.5 | 1.0 | GO:0043525 | positive regulation of neuron apoptotic process(GO:0043525) |
0.5 | 4.0 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.5 | 6.1 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.5 | 3.5 | GO:0042246 | tissue regeneration(GO:0042246) |
0.5 | 6.0 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.5 | 4.0 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.5 | 4.5 | GO:1903321 | negative regulation of protein modification by small protein conjugation or removal(GO:1903321) |
0.5 | 7.9 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.5 | 3.5 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.5 | 1.5 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.5 | 1.5 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.5 | 2.0 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.5 | 0.5 | GO:0015791 | polyol transport(GO:0015791) |
0.5 | 1.0 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.5 | 16.0 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.5 | 0.5 | GO:0043307 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
0.5 | 4.3 | GO:0043486 | histone exchange(GO:0043486) |
0.5 | 1.4 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.5 | 1.0 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) |
0.5 | 0.5 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.5 | 1.9 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.5 | 5.3 | GO:0042670 | retinal cone cell differentiation(GO:0042670) |
0.5 | 0.5 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.5 | 1.9 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.5 | 0.9 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.5 | 5.2 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.5 | 2.4 | GO:0061756 | leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.5 | 5.7 | GO:0070670 | response to interleukin-4(GO:0070670) cellular response to interleukin-4(GO:0071353) |
0.5 | 1.4 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.5 | 1.9 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.5 | 1.4 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.5 | 14.6 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
0.5 | 2.8 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.5 | 1.4 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.5 | 2.3 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.5 | 2.3 | GO:0006477 | protein sulfation(GO:0006477) |
0.5 | 3.3 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.5 | 1.4 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.5 | 2.3 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.5 | 0.9 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.5 | 1.9 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.5 | 0.9 | GO:0002027 | regulation of heart rate(GO:0002027) |
0.5 | 0.9 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.5 | 0.5 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.5 | 5.0 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.5 | 0.5 | GO:0071866 | apoptotic process in bone marrow(GO:0071839) regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
0.5 | 1.8 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.5 | 5.9 | GO:0001990 | regulation of systemic arterial blood pressure by hormone(GO:0001990) |
0.5 | 0.9 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.5 | 0.5 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.5 | 0.9 | GO:0048634 | regulation of muscle organ development(GO:0048634) |
0.4 | 1.3 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.4 | 0.4 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.4 | 1.3 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.4 | 0.9 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.4 | 3.1 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.4 | 1.8 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.4 | 2.2 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.4 | 7.5 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.4 | 1.8 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.4 | 1.3 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.4 | 3.9 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
0.4 | 1.7 | GO:0032418 | lysosome localization(GO:0032418) |
0.4 | 2.6 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.4 | 0.4 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.4 | 1.7 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.4 | 0.4 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.4 | 0.4 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.4 | 1.7 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.4 | 0.9 | GO:0060290 | transdifferentiation(GO:0060290) |
0.4 | 4.7 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.4 | 4.2 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.4 | 0.4 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.4 | 8.9 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.4 | 1.3 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.4 | 0.8 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.4 | 12.2 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.4 | 0.4 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.4 | 0.4 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.4 | 7.2 | GO:0016032 | viral process(GO:0016032) |
0.4 | 0.8 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.4 | 0.4 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.4 | 9.2 | GO:0030261 | chromosome condensation(GO:0030261) |
0.4 | 0.4 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.4 | 0.4 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.4 | 5.4 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.4 | 5.0 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.4 | 5.8 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.4 | 2.1 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.4 | 0.4 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.4 | 3.3 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.4 | 0.4 | GO:0009177 | pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.4 | 1.6 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.4 | 1.2 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.4 | 3.2 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.4 | 1.2 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.4 | 2.0 | GO:0080009 | mRNA methylation(GO:0080009) |
0.4 | 1.6 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.4 | 1.6 | GO:1901216 | positive regulation of neuron death(GO:1901216) |
0.4 | 0.4 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.4 | 2.4 | GO:0097320 | membrane tubulation(GO:0097320) |
0.4 | 2.8 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.4 | 3.2 | GO:0021930 | cell proliferation in hindbrain(GO:0021534) cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.4 | 1.2 | GO:0001706 | endoderm formation(GO:0001706) |
0.4 | 1.2 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.4 | 2.0 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.4 | 0.4 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.4 | 0.4 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.4 | 1.6 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.4 | 2.0 | GO:0060285 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.4 | 0.4 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.4 | 0.8 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.4 | 1.6 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.4 | 1.6 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.4 | 10.5 | GO:0050728 | negative regulation of inflammatory response(GO:0050728) |
0.4 | 2.3 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.4 | 0.4 | GO:0061009 | common bile duct development(GO:0061009) |
0.4 | 1.9 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.4 | 0.8 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.4 | 0.4 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.4 | 0.4 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.4 | 0.4 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.4 | 1.2 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.4 | 2.7 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.4 | 1.1 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.4 | 0.8 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
0.4 | 3.0 | GO:0006241 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
0.4 | 2.7 | GO:0043954 | cellular component maintenance(GO:0043954) |
0.4 | 0.4 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.4 | 1.5 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.4 | 0.8 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.4 | 1.9 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.4 | 1.5 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.4 | 0.4 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.4 | 22.9 | GO:0051028 | mRNA transport(GO:0051028) |
0.4 | 1.9 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.4 | 1.5 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.4 | 1.1 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.4 | 0.7 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.4 | 0.7 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.4 | 1.1 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.4 | 1.1 | GO:0051567 | histone H3-K9 methylation(GO:0051567) |
0.4 | 1.9 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.4 | 3.0 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.4 | 4.8 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.4 | 0.4 | GO:0032506 | cytokinetic process(GO:0032506) |
0.4 | 0.4 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.4 | 0.4 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.4 | 1.1 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.4 | 2.2 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.4 | 0.7 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.4 | 0.7 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.4 | 3.7 | GO:1990403 | embryonic brain development(GO:1990403) |
0.4 | 2.6 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.4 | 0.4 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.4 | 0.7 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.4 | 1.5 | GO:0002836 | positive regulation of response to tumor cell(GO:0002836) positive regulation of immune response to tumor cell(GO:0002839) |
0.4 | 0.4 | GO:0060443 | mammary gland morphogenesis(GO:0060443) |
0.4 | 2.2 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.4 | 1.1 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.4 | 1.8 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.4 | 1.4 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.4 | 0.7 | GO:1901881 | positive regulation of protein depolymerization(GO:1901881) |
0.4 | 1.4 | GO:0042796 | snRNA transcription from RNA polymerase II promoter(GO:0042795) snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.4 | 0.4 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.4 | 1.8 | GO:0070986 | left/right axis specification(GO:0070986) |
0.4 | 2.1 | GO:0072348 | sulfur compound transport(GO:0072348) |
0.4 | 1.1 | GO:0033622 | integrin activation(GO:0033622) |
0.4 | 1.8 | GO:0006108 | malate metabolic process(GO:0006108) |
0.4 | 7.8 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.4 | 1.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.4 | 0.7 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.4 | 1.4 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.4 | 0.7 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.4 | 1.1 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.4 | 10.5 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.4 | 1.1 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
0.4 | 0.4 | GO:0007619 | courtship behavior(GO:0007619) |
0.4 | 2.5 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.3 | 1.7 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.3 | 1.0 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.3 | 0.3 | GO:0034633 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.3 | 1.0 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.3 | 2.4 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.3 | 0.7 | GO:0021554 | optic nerve development(GO:0021554) |
0.3 | 2.8 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.3 | 0.3 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.3 | 0.3 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.3 | 93.4 | GO:0007283 | spermatogenesis(GO:0007283) |
0.3 | 0.3 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.3 | 2.8 | GO:0001562 | response to protozoan(GO:0001562) |
0.3 | 1.0 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.3 | 0.3 | GO:1990144 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.3 | 0.3 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.3 | 1.0 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.3 | 1.0 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.3 | 0.3 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.3 | 1.0 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.3 | 2.4 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.3 | 2.0 | GO:0097186 | amelogenesis(GO:0097186) |
0.3 | 2.0 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.3 | 0.7 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.3 | 9.5 | GO:0022900 | electron transport chain(GO:0022900) |
0.3 | 0.3 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.3 | 1.3 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.3 | 2.0 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.3 | 2.4 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.3 | 0.7 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.3 | 0.3 | GO:0009414 | response to water deprivation(GO:0009414) |
0.3 | 2.0 | GO:0044598 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.3 | 0.3 | GO:0047496 | vesicle transport along microtubule(GO:0047496) vesicle cytoskeletal trafficking(GO:0099518) |
0.3 | 5.0 | GO:0007602 | phototransduction(GO:0007602) |
0.3 | 2.3 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.3 | 0.3 | GO:0035646 | endosome to melanosome transport(GO:0035646) pigment accumulation(GO:0043476) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.3 | 0.3 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.3 | 0.3 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.3 | 1.0 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.3 | 0.3 | GO:0045686 | negative regulation of glial cell differentiation(GO:0045686) |
0.3 | 0.7 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.3 | 5.2 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.3 | 2.3 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) |
0.3 | 1.0 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
0.3 | 0.3 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.3 | 0.6 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.3 | 1.0 | GO:0003334 | keratinocyte development(GO:0003334) |
0.3 | 1.3 | GO:1903019 | negative regulation of glycoprotein metabolic process(GO:1903019) |
0.3 | 0.3 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.3 | 0.6 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) |
0.3 | 0.6 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.3 | 0.6 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.3 | 0.6 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.3 | 2.3 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.3 | 1.0 | GO:0000087 | mitotic M phase(GO:0000087) |
0.3 | 8.0 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.3 | 2.2 | GO:0046464 | neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
0.3 | 1.9 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.3 | 4.4 | GO:0035904 | aorta development(GO:0035904) |
0.3 | 0.6 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.3 | 3.8 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.3 | 4.4 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.3 | 0.9 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.3 | 0.3 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.3 | 1.6 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.3 | 0.9 | GO:0019627 | urea cycle(GO:0000050) arginine metabolic process(GO:0006525) arginine biosynthetic process(GO:0006526) urea metabolic process(GO:0019627) |
0.3 | 2.5 | GO:0033146 | regulation of intracellular estrogen receptor signaling pathway(GO:0033146) |
0.3 | 1.9 | GO:0032366 | intracellular sterol transport(GO:0032366) |
0.3 | 5.0 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.3 | 0.3 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.3 | 1.6 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.3 | 2.8 | GO:0048536 | spleen development(GO:0048536) |
0.3 | 19.7 | GO:0030198 | extracellular matrix organization(GO:0030198) |
0.3 | 3.8 | GO:0007043 | cell-cell junction assembly(GO:0007043) |
0.3 | 18.4 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.3 | 0.3 | GO:0032196 | transposition(GO:0032196) |
0.3 | 2.5 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
0.3 | 0.3 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.3 | 0.9 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.3 | 2.2 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.3 | 1.9 | GO:0072595 | maintenance of protein localization in organelle(GO:0072595) |
0.3 | 0.9 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.3 | 0.3 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.3 | 10.8 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.3 | 0.6 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.3 | 0.6 | GO:0015931 | nucleobase-containing compound transport(GO:0015931) |
0.3 | 0.9 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.3 | 0.9 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.3 | 0.3 | GO:0032898 | neurotrophin production(GO:0032898) |
0.3 | 0.9 | GO:0015879 | carnitine transport(GO:0015879) |
0.3 | 0.3 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.3 | 2.5 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.3 | 5.2 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.3 | 1.8 | GO:0080111 | DNA demethylation(GO:0080111) |
0.3 | 0.9 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.3 | 0.6 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.3 | 1.8 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.3 | 0.9 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.3 | 6.0 | GO:0015914 | phospholipid transport(GO:0015914) |
0.3 | 0.9 | GO:0002922 | positive regulation of humoral immune response(GO:0002922) |
0.3 | 0.6 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.3 | 0.9 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.3 | 0.3 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.3 | 1.8 | GO:0006388 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.3 | 0.9 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.3 | 0.3 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
0.3 | 0.9 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.3 | 0.6 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.3 | 5.3 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.3 | 6.4 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
0.3 | 0.3 | GO:0015747 | urate transport(GO:0015747) |
0.3 | 0.9 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.3 | 0.3 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.3 | 1.7 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.3 | 0.3 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.3 | 0.3 | GO:0019400 | alditol metabolic process(GO:0019400) |
0.3 | 7.2 | GO:0007517 | muscle organ development(GO:0007517) |
0.3 | 1.4 | GO:0060412 | ventricular septum morphogenesis(GO:0060412) |
0.3 | 1.4 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.3 | 0.6 | GO:0006415 | translational termination(GO:0006415) |
0.3 | 4.6 | GO:0030042 | actin filament depolymerization(GO:0030042) |
0.3 | 1.7 | GO:0042755 | eating behavior(GO:0042755) |
0.3 | 1.7 | GO:0098739 | sodium ion import across plasma membrane(GO:0098719) import across plasma membrane(GO:0098739) sodium ion import into cell(GO:1990118) |
0.3 | 0.6 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.3 | 1.4 | GO:0009154 | purine ribonucleotide catabolic process(GO:0009154) |
0.3 | 0.6 | GO:0090114 | COPII-coated vesicle budding(GO:0090114) |
0.3 | 0.3 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.3 | 0.6 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.3 | 0.3 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
0.3 | 2.5 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.3 | 0.6 | GO:0051882 | mitochondrial depolarization(GO:0051882) |
0.3 | 4.9 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
0.3 | 1.1 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.3 | 0.5 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
0.3 | 0.5 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.3 | 0.3 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
0.3 | 0.5 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.3 | 3.0 | GO:0001658 | branching involved in ureteric bud morphogenesis(GO:0001658) |
0.3 | 0.3 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.3 | 0.5 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.3 | 2.7 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.3 | 0.3 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.3 | 0.8 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.3 | 1.1 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.3 | 1.9 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.3 | 0.3 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.3 | 0.3 | GO:0002890 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.3 | 1.1 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
0.3 | 5.9 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.3 | 0.3 | GO:0003283 | atrial septum development(GO:0003283) |
0.3 | 0.8 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) establishment of protein localization to mitochondrial membrane(GO:0090151) |
0.3 | 0.5 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.3 | 4.5 | GO:1901998 | toxin transport(GO:1901998) |
0.3 | 3.9 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.3 | 1.3 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.3 | 0.5 | GO:0046473 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
0.3 | 0.5 | GO:0015695 | organic cation transport(GO:0015695) |
0.3 | 0.8 | GO:0042026 | protein refolding(GO:0042026) |
0.3 | 0.8 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.3 | 0.3 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.3 | 5.7 | GO:0031424 | keratinization(GO:0031424) |
0.3 | 0.3 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.3 | 2.3 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.3 | 2.3 | GO:1902883 | negative regulation of cellular response to oxidative stress(GO:1900408) negative regulation of response to oxidative stress(GO:1902883) |
0.3 | 1.5 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.3 | 0.3 | GO:0072553 | terminal button organization(GO:0072553) |
0.3 | 1.3 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.3 | 1.5 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.3 | 0.5 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.3 | 6.7 | GO:0009060 | aerobic respiration(GO:0009060) |
0.3 | 0.3 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.3 | 0.3 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.3 | 2.5 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.3 | 2.8 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.3 | 1.0 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.3 | 1.8 | GO:1902750 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.3 | 0.5 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.3 | 0.5 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.3 | 0.3 | GO:0048679 | regulation of axon regeneration(GO:0048679) |
0.3 | 0.3 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.3 | 1.0 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.3 | 0.3 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.3 | 0.5 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.3 | 5.3 | GO:0042130 | negative regulation of T cell proliferation(GO:0042130) |
0.3 | 3.3 | GO:0009411 | response to UV(GO:0009411) |
0.3 | 2.8 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.3 | 1.3 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.2 | 0.2 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
0.2 | 0.2 | GO:0071863 | regulation of cell proliferation in bone marrow(GO:0071863) |
0.2 | 3.0 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.2 | 0.5 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.2 | 4.4 | GO:0006953 | acute-phase response(GO:0006953) |
0.2 | 0.2 | GO:0048599 | oocyte development(GO:0048599) |
0.2 | 0.2 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.2 | 1.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 5.3 | GO:0000045 | autophagosome assembly(GO:0000045) |
0.2 | 0.2 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.2 | 1.0 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.2 | 0.2 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.2 | 0.7 | GO:0072528 | pyrimidine-containing compound biosynthetic process(GO:0072528) |
0.2 | 0.2 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.2 | 0.5 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.2 | 0.2 | GO:0048339 | paraxial mesoderm development(GO:0048339) |
0.2 | 0.2 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.2 | 0.5 | GO:0044788 | modulation by host of viral process(GO:0044788) |
0.2 | 0.7 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.2 | 0.5 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.2 | 2.8 | GO:0016180 | snRNA processing(GO:0016180) |
0.2 | 0.7 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.2 | 0.2 | GO:0034505 | tooth mineralization(GO:0034505) |
0.2 | 1.6 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.2 | 0.5 | GO:0048478 | replication fork protection(GO:0048478) |
0.2 | 0.2 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.2 | 0.9 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.2 | 0.9 | GO:0070417 | cellular response to cold(GO:0070417) |
0.2 | 0.2 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.2 | 0.5 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.2 | 0.7 | GO:1902101 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.2 | 1.6 | GO:0016233 | telomere capping(GO:0016233) |
0.2 | 1.4 | GO:0046415 | urate metabolic process(GO:0046415) |
0.2 | 0.9 | GO:0042255 | ribosome assembly(GO:0042255) |
0.2 | 0.5 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
0.2 | 0.2 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.2 | 1.6 | GO:0009303 | rRNA transcription(GO:0009303) |
0.2 | 0.2 | GO:0046541 | saliva secretion(GO:0046541) |
0.2 | 1.1 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.2 | 9.6 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) detection of chemical stimulus involved in sensory perception of taste(GO:0050912) sensory perception of bitter taste(GO:0050913) |
0.2 | 0.7 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.2 | 7.1 | GO:0034250 | positive regulation of cellular amide metabolic process(GO:0034250) |
0.2 | 0.7 | GO:0019348 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
0.2 | 0.2 | GO:0021697 | cerebellar cortex formation(GO:0021697) |
0.2 | 0.4 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.2 | 0.2 | GO:0010159 | specification of organ position(GO:0010159) |
0.2 | 2.4 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.2 | 0.9 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
0.2 | 3.7 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.2 | 0.2 | GO:0060416 | response to growth hormone(GO:0060416) |
0.2 | 2.4 | GO:0045116 | protein neddylation(GO:0045116) |
0.2 | 8.2 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.2 | 0.2 | GO:0035284 | rhombomere morphogenesis(GO:0021593) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.2 | 0.6 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.2 | 0.2 | GO:0048539 | bone marrow development(GO:0048539) |
0.2 | 0.2 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.2 | 0.4 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.2 | 0.2 | GO:0045605 | negative regulation of epidermal cell differentiation(GO:0045605) |
0.2 | 0.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.2 | 0.4 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.2 | 0.4 | GO:0046677 | response to antibiotic(GO:0046677) |
0.2 | 0.2 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
0.2 | 0.2 | GO:0032608 | interferon-beta production(GO:0032608) |
0.2 | 1.9 | GO:0060612 | adipose tissue development(GO:0060612) |
0.2 | 0.4 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.2 | 0.8 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.2 | 0.4 | GO:0031506 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.2 | 0.4 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.2 | 1.0 | GO:0046688 | response to copper ion(GO:0046688) |
0.2 | 0.4 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.2 | 0.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.2 | 0.2 | GO:0051153 | regulation of striated muscle cell differentiation(GO:0051153) |
0.2 | 0.2 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.2 | 0.2 | GO:0010182 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.2 | 0.4 | GO:0035303 | regulation of dephosphorylation(GO:0035303) |
0.2 | 0.6 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.2 | 0.4 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.2 | 0.2 | GO:0010883 | regulation of lipid storage(GO:0010883) |
0.2 | 1.6 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.2 | 0.2 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.2 | 0.4 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.2 | 0.6 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.2 | 0.4 | GO:0010661 | positive regulation of muscle cell apoptotic process(GO:0010661) |
0.2 | 0.2 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.2 | 4.6 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.2 | 2.6 | GO:0046323 | glucose import(GO:0046323) |
0.2 | 1.0 | GO:0070374 | positive regulation of ERK1 and ERK2 cascade(GO:0070374) |
0.2 | 0.2 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.2 | 0.2 | GO:0060099 | regulation of phagocytosis, engulfment(GO:0060099) |
0.2 | 1.2 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.2 | 0.6 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.2 | 2.3 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.2 | 1.3 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.2 | 1.1 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.2 | 1.7 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.2 | 0.2 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.2 | 0.2 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.2 | 0.6 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.2 | 1.3 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.2 | 0.9 | GO:1990001 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.2 | 0.7 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.2 | 0.2 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
0.2 | 0.2 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.2 | 0.2 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.2 | 0.2 | GO:0046824 | positive regulation of nucleocytoplasmic transport(GO:0046824) |
0.2 | 17.9 | GO:0009615 | response to virus(GO:0009615) |
0.2 | 0.6 | GO:0007520 | myoblast fusion(GO:0007520) |
0.2 | 0.2 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.2 | 1.7 | GO:0006414 | translational elongation(GO:0006414) |
0.2 | 0.6 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.2 | 0.7 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.2 | 0.5 | GO:0002076 | osteoblast development(GO:0002076) |
0.2 | 0.4 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.2 | 1.5 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.2 | 4.2 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
0.2 | 0.2 | GO:0002215 | defense response to nematode(GO:0002215) |
0.2 | 0.2 | GO:0048532 | anatomical structure arrangement(GO:0048532) |
0.2 | 0.4 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.2 | 1.1 | GO:0002673 | regulation of acute inflammatory response(GO:0002673) |
0.2 | 0.4 | GO:0010907 | positive regulation of glucose metabolic process(GO:0010907) |
0.2 | 1.4 | GO:0033233 | regulation of protein sumoylation(GO:0033233) |
0.2 | 0.2 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.2 | 2.7 | GO:0006826 | iron ion transport(GO:0006826) |
0.2 | 0.4 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.2 | 0.2 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
0.2 | 0.2 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) |
0.2 | 1.8 | GO:0048477 | oogenesis(GO:0048477) |
0.2 | 0.2 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.2 | 1.4 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.2 | 0.9 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.2 | 0.7 | GO:0048535 | lymph node development(GO:0048535) |
0.2 | 0.3 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
0.2 | 0.2 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.2 | 0.3 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.2 | 1.2 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
0.2 | 0.3 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.2 | 0.2 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.2 | 0.9 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.2 | 0.2 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.2 | 0.3 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.2 | 0.2 | GO:0033058 | directional locomotion(GO:0033058) |
0.2 | 4.9 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.2 | 2.5 | GO:0034612 | response to tumor necrosis factor(GO:0034612) |
0.2 | 3.2 | GO:0031398 | positive regulation of protein ubiquitination(GO:0031398) |
0.2 | 0.3 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.2 | 16.7 | GO:0000375 | RNA splicing, via transesterification reactions(GO:0000375) |
0.2 | 0.3 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.2 | 0.7 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.2 | 1.0 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.2 | 0.5 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.2 | 0.3 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.2 | 0.7 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.2 | 0.5 | GO:0003014 | renal system process(GO:0003014) |
0.2 | 0.2 | GO:2001055 | endothelial cell fate specification(GO:0060847) positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.2 | 0.3 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.2 | 0.8 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.2 | 0.3 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) |
0.2 | 12.6 | GO:0006575 | cellular modified amino acid metabolic process(GO:0006575) |
0.2 | 0.3 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.2 | 10.5 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.2 | 4.3 | GO:0030073 | insulin secretion(GO:0030073) |
0.2 | 0.3 | GO:0030576 | Cajal body organization(GO:0030576) |
0.2 | 0.8 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.2 | 4.8 | GO:0030307 | positive regulation of cell growth(GO:0030307) |
0.2 | 0.2 | GO:0043092 | L-amino acid import(GO:0043092) |
0.2 | 1.3 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.2 | 0.3 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.2 | 0.2 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.2 | 0.3 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.2 | 6.9 | GO:0007338 | single fertilization(GO:0007338) |
0.2 | 0.3 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.2 | 11.2 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.2 | 0.5 | GO:0007144 | female meiosis I(GO:0007144) |
0.2 | 1.3 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.2 | 0.2 | GO:0007228 | signal transduction downstream of smoothened(GO:0007227) positive regulation of hh target transcription factor activity(GO:0007228) |
0.2 | 0.3 | GO:1903556 | negative regulation of tumor necrosis factor superfamily cytokine production(GO:1903556) |
0.2 | 13.2 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
0.2 | 0.2 | GO:0030878 | thyroid gland development(GO:0030878) |
0.2 | 0.9 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.2 | 0.3 | GO:0034695 | response to prostaglandin E(GO:0034695) |
0.2 | 0.2 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.2 | 0.3 | GO:0046015 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) regulation of transcription by glucose(GO:0046015) positive regulation of transcription by glucose(GO:0046016) |
0.2 | 1.1 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.2 | 0.5 | GO:0014002 | astrocyte development(GO:0014002) |
0.2 | 0.3 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.2 | 0.3 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.1 | 0.1 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 0.3 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.1 | 0.6 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 2.2 | GO:2000648 | positive regulation of stem cell proliferation(GO:2000648) |
0.1 | 0.7 | GO:0071359 | cellular response to dsRNA(GO:0071359) |
0.1 | 0.1 | GO:0006101 | citrate metabolic process(GO:0006101) |
0.1 | 0.3 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.1 | 0.1 | GO:0034694 | response to prostaglandin(GO:0034694) |
0.1 | 1.0 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.3 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
0.1 | 0.1 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.1 | 0.1 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.1 | 0.1 | GO:0034113 | heterotypic cell-cell adhesion(GO:0034113) |
0.1 | 0.1 | GO:0045023 | G0 to G1 transition(GO:0045023) regulation of G0 to G1 transition(GO:0070316) |
0.1 | 0.3 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 0.3 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.4 | GO:0010359 | regulation of anion channel activity(GO:0010359) negative regulation of anion channel activity(GO:0010360) negative regulation of anion transmembrane transport(GO:1903960) |
0.1 | 12.0 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.1 | 0.6 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.1 | 0.3 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.7 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.1 | 0.3 | GO:0060969 | negative regulation of gene silencing(GO:0060969) |
0.1 | 0.4 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.7 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 2.3 | GO:0050818 | regulation of coagulation(GO:0050818) |
0.1 | 0.6 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.1 | 0.1 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.1 | 0.1 | GO:0018158 | protein oxidation(GO:0018158) |
0.1 | 0.4 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.1 | 1.5 | GO:0050714 | positive regulation of protein secretion(GO:0050714) |
0.1 | 0.4 | GO:1901099 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.1 | 0.5 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.1 | 0.5 | GO:0051168 | nuclear export(GO:0051168) |
0.1 | 0.4 | GO:0045777 | positive regulation of blood pressure(GO:0045777) |
0.1 | 0.4 | GO:0034397 | telomere localization(GO:0034397) |
0.1 | 8.3 | GO:0030036 | actin cytoskeleton organization(GO:0030036) |
0.1 | 0.5 | GO:0045922 | negative regulation of fatty acid metabolic process(GO:0045922) |
0.1 | 0.1 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.1 | 0.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.7 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.1 | 0.3 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 1.3 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.1 | 0.9 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.1 | 0.1 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.1 | 0.1 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 2.3 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.4 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.1 | 0.1 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.1 | 0.1 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.1 | 0.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.2 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.1 | 1.0 | GO:0031124 | mRNA 3'-end processing(GO:0031124) |
0.1 | 0.2 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.1 | 0.2 | GO:0021696 | cerebellar cortex morphogenesis(GO:0021696) |
0.1 | 0.1 | GO:0098781 | ncRNA transcription(GO:0098781) |
0.1 | 0.1 | GO:0035588 | G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.1 | 1.2 | GO:0007569 | cell aging(GO:0007569) |
0.1 | 0.2 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 6.7 | GO:0043413 | protein glycosylation(GO:0006486) macromolecule glycosylation(GO:0043413) |
0.1 | 0.5 | GO:0006213 | pyrimidine nucleoside metabolic process(GO:0006213) |
0.1 | 0.2 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.1 | 0.2 | GO:0071025 | RNA surveillance(GO:0071025) |
0.1 | 0.2 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 0.1 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.1 | 0.1 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.1 | 0.2 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.1 | 0.2 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.1 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 0.2 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.1 | 0.1 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 0.7 | GO:0051701 | interaction with host(GO:0051701) |
0.1 | 0.2 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.1 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.1 | 0.2 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.1 | 0.2 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 5.7 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.3 | GO:0072527 | pyrimidine-containing compound metabolic process(GO:0072527) |
0.1 | 0.9 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.1 | 0.1 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.1 | 0.8 | GO:0022408 | negative regulation of cell-cell adhesion(GO:0022408) |
0.1 | 0.1 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.1 | 0.1 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.1 | 0.3 | GO:0070633 | transepithelial transport(GO:0070633) |
0.1 | 0.1 | GO:0048840 | otolith development(GO:0048840) |
0.1 | 0.3 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.1 | 0.1 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
0.1 | 0.1 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.1 | 0.2 | GO:0070861 | regulation of protein exit from endoplasmic reticulum(GO:0070861) negative regulation of ERAD pathway(GO:1904293) |
0.1 | 0.2 | GO:0021517 | ventral spinal cord development(GO:0021517) |
0.1 | 4.1 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 1.3 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.1 | 0.7 | GO:0015807 | L-amino acid transport(GO:0015807) |
0.1 | 0.2 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.3 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.1 | 1.1 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.1 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
0.1 | 0.1 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.1 | 0.7 | GO:0050657 | nucleic acid transport(GO:0050657) RNA transport(GO:0050658) |
0.1 | 0.4 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.1 | 1.1 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 2.3 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.1 | 0.4 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.1 | 3.4 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.1 | 0.8 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.2 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.1 | 0.3 | GO:0003281 | ventricular septum development(GO:0003281) |
0.1 | 0.2 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.1 | 0.5 | GO:0042542 | response to hydrogen peroxide(GO:0042542) |
0.1 | 2.3 | GO:0006400 | tRNA modification(GO:0006400) |
0.1 | 0.8 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.1 | 0.2 | GO:0002347 | response to tumor cell(GO:0002347) |
0.1 | 0.1 | GO:1901623 | regulation of lymphocyte chemotaxis(GO:1901623) |
0.1 | 0.1 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.1 | 0.2 | GO:0043328 | endosome transport via multivesicular body sorting pathway(GO:0032509) late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.1 | 0.1 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.1 | 1.7 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.3 | GO:0002507 | tolerance induction(GO:0002507) |
0.1 | 0.5 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.1 | 0.1 | GO:0032272 | negative regulation of protein polymerization(GO:0032272) |
0.1 | 0.2 | GO:0002763 | positive regulation of myeloid leukocyte differentiation(GO:0002763) |
0.1 | 0.4 | GO:0010595 | positive regulation of endothelial cell migration(GO:0010595) |
0.1 | 0.3 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.1 | 0.1 | GO:0001836 | release of cytochrome c from mitochondria(GO:0001836) |
0.1 | 0.2 | GO:0043586 | tongue development(GO:0043586) |
0.1 | 0.2 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 0.3 | GO:0001570 | vasculogenesis(GO:0001570) |
0.1 | 0.1 | GO:0032682 | negative regulation of chemokine production(GO:0032682) |
0.1 | 0.1 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.1 | 1.0 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.1 | GO:1900372 | negative regulation of nucleotide biosynthetic process(GO:0030809) negative regulation of purine nucleotide biosynthetic process(GO:1900372) |
0.1 | 0.4 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.1 | 0.1 | GO:0046640 | regulation of alpha-beta T cell proliferation(GO:0046640) |
0.1 | 0.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.1 | 4.9 | GO:0002237 | response to molecule of bacterial origin(GO:0002237) |
0.1 | 0.1 | GO:1902931 | negative regulation of alcohol biosynthetic process(GO:1902931) |
0.1 | 0.1 | GO:0044320 | cellular response to leptin stimulus(GO:0044320) |
0.1 | 0.2 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.1 | 0.1 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.1 | 0.2 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.2 | GO:0006560 | proline metabolic process(GO:0006560) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.1 | GO:0090594 | wound healing involved in inflammatory response(GO:0002246) connective tissue replacement involved in inflammatory response wound healing(GO:0002248) inflammatory response to wounding(GO:0090594) connective tissue replacement(GO:0097709) |
0.1 | 0.1 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
0.1 | 0.1 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
0.1 | 0.8 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.1 | 1.0 | GO:0009408 | response to heat(GO:0009408) |
0.1 | 0.3 | GO:0043507 | positive regulation of JUN kinase activity(GO:0043507) |
0.1 | 0.3 | GO:0001541 | ovarian follicle development(GO:0001541) |
0.1 | 0.2 | GO:0002438 | acute inflammatory response to antigenic stimulus(GO:0002438) |
0.1 | 2.6 | GO:0002757 | immune response-activating signal transduction(GO:0002757) |
0.1 | 0.1 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.1 | 0.1 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.1 | 0.1 | GO:0014910 | regulation of smooth muscle cell migration(GO:0014910) |
0.1 | 1.5 | GO:0006665 | sphingolipid metabolic process(GO:0006665) |
0.1 | 0.2 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.1 | 0.1 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.1 | 0.2 | GO:0072665 | protein localization to vacuole(GO:0072665) |
0.1 | 0.2 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.1 | 0.6 | GO:0001783 | B cell apoptotic process(GO:0001783) |
0.1 | 0.2 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.1 | 0.1 | GO:0034204 | lipid translocation(GO:0034204) |
0.1 | 0.1 | GO:0032329 | serine transport(GO:0032329) |
0.1 | 0.2 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
0.1 | 0.2 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.2 | GO:0061430 | bone trabecula morphogenesis(GO:0061430) |
0.1 | 0.1 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.1 | 0.2 | GO:0021695 | cerebellar cortex development(GO:0021695) |
0.1 | 0.1 | GO:0051651 | maintenance of location in cell(GO:0051651) |
0.1 | 0.1 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.1 | 0.2 | GO:0070266 | necroptotic process(GO:0070266) |
0.1 | 0.1 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.1 | 2.7 | GO:0043010 | camera-type eye development(GO:0043010) |
0.1 | 0.1 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.1 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.1 | 1.1 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 0.4 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 1.1 | GO:0042177 | negative regulation of protein catabolic process(GO:0042177) |
0.1 | 0.3 | GO:0021983 | pituitary gland development(GO:0021983) |
0.1 | 0.2 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.1 | 0.4 | GO:0035690 | cellular response to drug(GO:0035690) |
0.1 | 1.8 | GO:0051493 | regulation of cytoskeleton organization(GO:0051493) |
0.1 | 0.1 | GO:0043383 | negative T cell selection(GO:0043383) |
0.1 | 0.1 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.1 | 0.1 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.1 | 0.5 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.1 | 0.1 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.1 | 0.5 | GO:0048659 | smooth muscle cell proliferation(GO:0048659) |
0.1 | 0.2 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.1 | 1.2 | GO:0001822 | kidney development(GO:0001822) |
0.1 | 0.1 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.1 | 0.2 | GO:1901068 | guanosine-containing compound metabolic process(GO:1901068) |
0.1 | 0.1 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.1 | 0.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 0.1 | GO:0021545 | cranial nerve development(GO:0021545) |
0.1 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.4 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.1 | 0.1 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.3 | GO:0043576 | regulation of respiratory gaseous exchange(GO:0043576) |
0.1 | 0.1 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) positive regulation of leukocyte apoptotic process(GO:2000108) |
0.1 | 0.1 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.1 | 0.2 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.1 | GO:0006171 | cAMP biosynthetic process(GO:0006171) |
0.1 | 0.1 | GO:0090077 | foam cell differentiation(GO:0090077) |
0.1 | 0.1 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.1 | 0.4 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 0.1 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.1 | 1.5 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.1 | 15.2 | GO:0050907 | detection of chemical stimulus involved in sensory perception(GO:0050907) |
0.1 | 0.1 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 0.1 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.1 | GO:0051132 | NK T cell activation(GO:0051132) |
0.1 | 0.1 | GO:0015669 | gas transport(GO:0015669) |
0.1 | 0.2 | GO:0018904 | ether metabolic process(GO:0018904) |
0.1 | 6.3 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.1 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.2 | GO:0070371 | ERK1 and ERK2 cascade(GO:0070371) |
0.1 | 0.4 | GO:0015833 | peptide transport(GO:0015833) |
0.1 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.3 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.5 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.1 | 0.1 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 0.5 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.1 | 0.1 | GO:0008207 | C21-steroid hormone metabolic process(GO:0008207) |
0.1 | 0.1 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.1 | 0.2 | GO:0007135 | meiosis II(GO:0007135) |
0.1 | 0.2 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.1 | 0.7 | GO:0090501 | RNA phosphodiester bond hydrolysis(GO:0090501) |
0.1 | 0.2 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.1 | 0.2 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.1 | 0.1 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.1 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.0 | 0.1 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.0 | 0.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.0 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.1 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.0 | 0.0 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.0 | 0.0 | GO:0051645 | Golgi localization(GO:0051645) |
0.0 | 0.2 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.0 | 0.2 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.0 | 0.1 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.0 | 0.1 | GO:0030279 | negative regulation of ossification(GO:0030279) |
0.0 | 0.1 | GO:0001837 | epithelial to mesenchymal transition(GO:0001837) |
0.0 | 0.1 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.0 | 0.6 | GO:0048663 | neuron fate commitment(GO:0048663) |
0.0 | 4.8 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.0 | 0.5 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
0.0 | 0.0 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.0 | 0.1 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.0 | 0.0 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.0 | 0.1 | GO:0042991 | transcription factor import into nucleus(GO:0042991) |
0.0 | 0.1 | GO:0031589 | cell-substrate adhesion(GO:0031589) |
0.0 | 0.2 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 0.0 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.0 | 0.4 | GO:1901343 | negative regulation of vasculature development(GO:1901343) |
0.0 | 0.1 | GO:0007162 | negative regulation of cell adhesion(GO:0007162) |
0.0 | 0.0 | GO:0044838 | cell quiescence(GO:0044838) |
0.0 | 0.0 | GO:0044060 | regulation of endocrine process(GO:0044060) |
0.0 | 0.0 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.0 | 0.1 | GO:1901017 | negative regulation of potassium ion transmembrane transporter activity(GO:1901017) |
0.0 | 0.0 | GO:0048668 | collateral sprouting(GO:0048668) |
0.0 | 0.1 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.0 | 0.0 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.0 | 0.2 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.0 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.0 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.0 | 0.1 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.0 | 0.1 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.0 | 0.1 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.0 | 0.1 | GO:0035136 | forelimb morphogenesis(GO:0035136) |
0.0 | 0.0 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.0 | 0.0 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.0 | 0.1 | GO:0048678 | response to axon injury(GO:0048678) |
0.0 | 0.0 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.2 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.0 | 0.1 | GO:0036035 | osteoclast development(GO:0036035) |
0.0 | 0.2 | GO:0009166 | nucleotide catabolic process(GO:0009166) |
0.0 | 0.0 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.0 | 0.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.0 | 0.3 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
0.0 | 0.1 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.0 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.0 | 0.1 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.0 | 0.2 | GO:0014065 | phosphatidylinositol 3-kinase signaling(GO:0014065) |
0.0 | 0.0 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.0 | 0.1 | GO:0033504 | floor plate development(GO:0033504) |
0.0 | 0.0 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.0 | 0.2 | GO:2000177 | regulation of neural precursor cell proliferation(GO:2000177) |
0.0 | 0.0 | GO:0031348 | negative regulation of defense response(GO:0031348) |
0.0 | 0.0 | GO:0061037 | negative regulation of cartilage development(GO:0061037) |
0.0 | 0.0 | GO:0016577 | histone demethylation(GO:0016577) |
0.0 | 0.0 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.0 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.0 | GO:0070988 | demethylation(GO:0070988) |
0.0 | 0.0 | GO:0010039 | response to iron ion(GO:0010039) |
0.0 | 0.0 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.0 | 0.0 | GO:0051341 | regulation of oxidoreductase activity(GO:0051341) |
0.0 | 0.0 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.0 | 0.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.0 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.0 | 0.2 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
0.0 | 0.0 | GO:0090148 | membrane fission(GO:0090148) |
0.0 | 0.0 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.0 | 0.1 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.2 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
0.0 | 0.0 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.0 | 0.0 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.0 | 0.0 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.0 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.1 | GO:0009880 | embryonic pattern specification(GO:0009880) |
0.0 | 0.0 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
0.0 | 0.1 | GO:0045576 | mast cell activation(GO:0045576) |
0.0 | 0.0 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.0 | 0.0 | GO:0000768 | syncytium formation by plasma membrane fusion(GO:0000768) |
0.0 | 1.0 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 0.0 | GO:1904478 | regulation of intestinal absorption(GO:1904478) |
0.0 | 0.0 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.0 | 0.1 | GO:0022600 | digestive system process(GO:0022600) |
0.0 | 0.0 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
0.0 | 0.0 | GO:0045620 | negative regulation of lymphocyte differentiation(GO:0045620) |
0.0 | 0.0 | GO:0071435 | potassium ion export(GO:0071435) |
0.0 | 0.0 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.0 | 0.0 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.0 | 0.0 | GO:0040014 | regulation of multicellular organism growth(GO:0040014) |
0.0 | 0.0 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
0.0 | 0.0 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.0 | 0.0 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.0 | 0.0 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.0 | 0.0 | GO:0090504 | epiboly(GO:0090504) |
0.0 | 0.0 | GO:0007625 | grooming behavior(GO:0007625) |
0.0 | 0.0 | GO:0017145 | stem cell division(GO:0017145) |
0.0 | 0.0 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.0 | 0.0 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.0 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.0 | 0.0 | GO:0090382 | phagosome maturation(GO:0090382) |
0.0 | 0.0 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.0 | 0.2 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.0 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.0 | 0.0 | GO:0035137 | hindlimb morphogenesis(GO:0035137) |
0.0 | 0.0 | GO:0048483 | autonomic nervous system development(GO:0048483) |
0.0 | 0.0 | GO:0010662 | regulation of striated muscle cell apoptotic process(GO:0010662) |
0.0 | 9.4 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.0 | GO:0001974 | blood vessel remodeling(GO:0001974) |
0.0 | 0.0 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.0 | 0.0 | GO:0050707 | regulation of cytokine secretion(GO:0050707) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
15.7 | 47.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
14.9 | 44.7 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
10.5 | 136.7 | GO:0005916 | fascia adherens(GO:0005916) |
9.7 | 29.1 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
9.2 | 27.7 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
8.3 | 33.0 | GO:0005927 | muscle tendon junction(GO:0005927) |
7.7 | 46.3 | GO:0005859 | muscle myosin complex(GO:0005859) |
7.2 | 57.2 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
7.1 | 21.2 | GO:0031417 | NatC complex(GO:0031417) |
6.5 | 39.3 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
5.7 | 51.2 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
5.5 | 38.2 | GO:0033263 | CORVET complex(GO:0033263) |
5.3 | 26.3 | GO:0031430 | M band(GO:0031430) |
5.2 | 26.1 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
4.9 | 19.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
4.9 | 63.1 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
4.8 | 19.1 | GO:0005610 | laminin-5 complex(GO:0005610) |
4.8 | 57.3 | GO:0031672 | A band(GO:0031672) |
4.4 | 13.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
4.4 | 17.6 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
4.3 | 377.9 | GO:0030018 | Z disc(GO:0030018) |
4.1 | 24.6 | GO:0031983 | vesicle lumen(GO:0031983) |
3.9 | 31.0 | GO:0042587 | glycogen granule(GO:0042587) |
3.6 | 7.3 | GO:0043259 | laminin-10 complex(GO:0043259) |
3.6 | 50.9 | GO:0043196 | varicosity(GO:0043196) |
3.6 | 21.6 | GO:0016012 | sarcoglycan complex(GO:0016012) |
3.3 | 9.8 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
3.2 | 9.6 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
3.0 | 9.1 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
2.7 | 13.7 | GO:0033093 | Weibel-Palade body(GO:0033093) |
2.7 | 8.2 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
2.7 | 45.6 | GO:0005614 | interstitial matrix(GO:0005614) |
2.6 | 28.6 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
2.5 | 12.7 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
2.5 | 5.0 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
2.5 | 17.2 | GO:0031988 | membrane-bounded vesicle(GO:0031988) |
2.4 | 21.7 | GO:0043034 | costamere(GO:0043034) |
2.4 | 7.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
2.3 | 7.0 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
2.3 | 46.3 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
2.3 | 9.1 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
2.3 | 22.6 | GO:0030061 | mitochondrial crista(GO:0030061) |
2.3 | 6.8 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
2.2 | 8.8 | GO:0030478 | actin cap(GO:0030478) |
2.2 | 6.5 | GO:0005712 | chiasma(GO:0005712) |
2.1 | 59.5 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
2.0 | 26.6 | GO:0097431 | mitotic spindle pole(GO:0097431) |
2.0 | 122.3 | GO:0043292 | contractile fiber(GO:0043292) |
2.0 | 7.9 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.9 | 11.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.9 | 22.7 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
1.8 | 18.4 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.8 | 5.5 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
1.8 | 12.7 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
1.8 | 104.8 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
1.8 | 10.8 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
1.8 | 53.7 | GO:0009925 | basal plasma membrane(GO:0009925) |
1.8 | 3.6 | GO:0032437 | cuticular plate(GO:0032437) |
1.8 | 3.5 | GO:0032127 | dense core granule membrane(GO:0032127) |
1.8 | 40.5 | GO:0030315 | T-tubule(GO:0030315) |
1.8 | 84.2 | GO:0042641 | actomyosin(GO:0042641) |
1.7 | 34.9 | GO:0008305 | integrin complex(GO:0008305) |
1.7 | 6.9 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
1.7 | 5.0 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
1.7 | 5.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
1.6 | 6.5 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
1.6 | 6.4 | GO:0019815 | B cell receptor complex(GO:0019815) |
1.6 | 6.3 | GO:0000322 | storage vacuole(GO:0000322) |
1.6 | 10.9 | GO:0016528 | sarcoplasm(GO:0016528) |
1.5 | 1.5 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
1.5 | 6.1 | GO:0000938 | GARP complex(GO:0000938) |
1.5 | 4.5 | GO:0044308 | axonal spine(GO:0044308) |
1.5 | 7.5 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
1.5 | 16.5 | GO:0030126 | COPI vesicle coat(GO:0030126) |
1.5 | 7.4 | GO:0061617 | MICOS complex(GO:0061617) |
1.5 | 4.4 | GO:0097413 | Lewy body(GO:0097413) |
1.4 | 7.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
1.4 | 5.7 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
1.4 | 15.4 | GO:0042627 | chylomicron(GO:0042627) |
1.4 | 8.3 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
1.4 | 5.5 | GO:0071797 | LUBAC complex(GO:0071797) |
1.4 | 12.4 | GO:0097208 | alveolar lamellar body(GO:0097208) |
1.4 | 30.2 | GO:0090544 | BAF-type complex(GO:0090544) |
1.4 | 4.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
1.4 | 5.5 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
1.4 | 2.7 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
1.4 | 8.2 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
1.4 | 40.7 | GO:0005921 | gap junction(GO:0005921) |
1.3 | 8.1 | GO:0045180 | basal cortex(GO:0045180) |
1.3 | 5.3 | GO:0071817 | MMXD complex(GO:0071817) |
1.3 | 10.5 | GO:0045179 | apical cortex(GO:0045179) |
1.3 | 1.3 | GO:0005642 | annulate lamellae(GO:0005642) |
1.3 | 58.4 | GO:0042383 | sarcolemma(GO:0042383) |
1.3 | 3.9 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
1.3 | 8.9 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
1.2 | 13.5 | GO:0005605 | basal lamina(GO:0005605) |
1.2 | 28.2 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
1.2 | 13.3 | GO:0032279 | asymmetric synapse(GO:0032279) |
1.2 | 1.2 | GO:0034464 | BBSome(GO:0034464) |
1.2 | 11.6 | GO:0034704 | calcium channel complex(GO:0034704) |
1.1 | 5.7 | GO:0032009 | early phagosome(GO:0032009) |
1.1 | 21.8 | GO:0030057 | desmosome(GO:0030057) |
1.1 | 13.6 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
1.1 | 4.5 | GO:0045298 | tubulin complex(GO:0045298) |
1.1 | 8.9 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
1.1 | 15.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
1.1 | 10.7 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
1.1 | 6.4 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
1.0 | 16.7 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
1.0 | 11.4 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
1.0 | 6.2 | GO:0032584 | growth cone membrane(GO:0032584) |
1.0 | 6.0 | GO:0072687 | meiotic spindle(GO:0072687) |
1.0 | 6.0 | GO:0051286 | cell tip(GO:0051286) |
1.0 | 12.8 | GO:0000974 | Prp19 complex(GO:0000974) |
1.0 | 12.8 | GO:0005903 | brush border(GO:0005903) |
1.0 | 14.7 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
1.0 | 7.9 | GO:0000800 | lateral element(GO:0000800) |
1.0 | 13.3 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.9 | 2.8 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.9 | 5.7 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.9 | 3.8 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.9 | 12.2 | GO:0000242 | pericentriolar material(GO:0000242) |
0.9 | 28.0 | GO:0031901 | early endosome membrane(GO:0031901) |
0.9 | 2.8 | GO:0031528 | microvillus membrane(GO:0031528) |
0.9 | 3.7 | GO:0044194 | cytolytic granule(GO:0044194) |
0.9 | 4.6 | GO:0071439 | clathrin complex(GO:0071439) |
0.9 | 3.6 | GO:0071556 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) lumenal side of membrane(GO:0098576) |
0.9 | 8.1 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.9 | 8.8 | GO:0097440 | apical dendrite(GO:0097440) |
0.9 | 2.6 | GO:0032433 | filopodium tip(GO:0032433) |
0.9 | 6.9 | GO:0070652 | HAUS complex(GO:0070652) |
0.9 | 3.5 | GO:0035339 | SPOTS complex(GO:0035339) |
0.9 | 3.4 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.9 | 0.9 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.9 | 26.5 | GO:0005901 | caveola(GO:0005901) |
0.8 | 3.4 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.8 | 2.5 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.8 | 2.5 | GO:0042583 | chromaffin granule(GO:0042583) |
0.8 | 7.5 | GO:0031932 | TORC2 complex(GO:0031932) |
0.8 | 9.9 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.8 | 5.0 | GO:0070852 | cell body fiber(GO:0070852) |
0.8 | 4.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.8 | 3.3 | GO:0005686 | U2 snRNP(GO:0005686) |
0.8 | 2.4 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.8 | 27.2 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.8 | 4.0 | GO:0042629 | mast cell granule(GO:0042629) |
0.8 | 7.9 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.8 | 4.7 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.8 | 7.1 | GO:0002102 | podosome(GO:0002102) |
0.8 | 18.0 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.8 | 8.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.8 | 18.6 | GO:0001772 | immunological synapse(GO:0001772) |
0.8 | 0.8 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.8 | 75.1 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.8 | 5.4 | GO:0031143 | pseudopodium(GO:0031143) |
0.8 | 6.9 | GO:0005869 | dynactin complex(GO:0005869) |
0.8 | 0.8 | GO:0000811 | GINS complex(GO:0000811) |
0.8 | 0.8 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.8 | 10.6 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.7 | 2.2 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.7 | 3.0 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.7 | 25.6 | GO:0005884 | actin filament(GO:0005884) |
0.7 | 2.2 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.7 | 2.2 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.7 | 1.5 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.7 | 0.7 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.7 | 6.5 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.7 | 7.9 | GO:0046930 | pore complex(GO:0046930) |
0.7 | 85.2 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.7 | 7.1 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.7 | 10.7 | GO:0097225 | sperm midpiece(GO:0097225) |
0.7 | 2.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.7 | 0.7 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.7 | 2.8 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.7 | 2.8 | GO:0016600 | flotillin complex(GO:0016600) |
0.7 | 4.2 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.7 | 2.1 | GO:1990393 | 3M complex(GO:1990393) |
0.7 | 162.6 | GO:0005924 | cell-substrate adherens junction(GO:0005924) |
0.7 | 0.7 | GO:0097255 | R2TP complex(GO:0097255) |
0.7 | 7.4 | GO:0016580 | Sin3 complex(GO:0016580) |
0.7 | 1.3 | GO:0000346 | transcription export complex(GO:0000346) |
0.7 | 9.4 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.7 | 80.4 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.7 | 2.7 | GO:0030424 | axon(GO:0030424) |
0.7 | 3.3 | GO:0071547 | piP-body(GO:0071547) |
0.7 | 2.0 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.6 | 1.9 | GO:0048179 | activin receptor complex(GO:0048179) |
0.6 | 7.8 | GO:0000145 | exocyst(GO:0000145) |
0.6 | 0.6 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.6 | 21.9 | GO:0005776 | autophagosome(GO:0005776) |
0.6 | 0.6 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.6 | 29.4 | GO:0005871 | kinesin complex(GO:0005871) |
0.6 | 28.7 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.6 | 1.9 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.6 | 6.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.6 | 4.4 | GO:0043234 | protein complex(GO:0043234) |
0.6 | 12.6 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.6 | 1.9 | GO:0036396 | MIS complex(GO:0036396) |
0.6 | 0.6 | GO:0043204 | perikaryon(GO:0043204) |
0.6 | 2.5 | GO:0000805 | X chromosome(GO:0000805) |
0.6 | 1.9 | GO:0036156 | inner dynein arm(GO:0036156) |
0.6 | 92.4 | GO:0031965 | nuclear membrane(GO:0031965) |
0.6 | 1.2 | GO:0033268 | node of Ranvier(GO:0033268) |
0.6 | 72.6 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.6 | 21.9 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.6 | 1.2 | GO:0070552 | BRISC complex(GO:0070552) |
0.6 | 4.8 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.6 | 1.7 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.6 | 38.8 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.6 | 24.8 | GO:0005811 | lipid particle(GO:0005811) |
0.6 | 6.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.6 | 1.7 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.6 | 1.1 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.6 | 7.4 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.6 | 4.5 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.6 | 4.0 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.6 | 4.0 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.6 | 7.9 | GO:0016592 | mediator complex(GO:0016592) |
0.6 | 7.2 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.6 | 6.1 | GO:0034451 | centriolar satellite(GO:0034451) |
0.5 | 1.6 | GO:0043203 | axon hillock(GO:0043203) |
0.5 | 1.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.5 | 56.8 | GO:0005635 | nuclear envelope(GO:0005635) |
0.5 | 1.6 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.5 | 4.8 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.5 | 42.4 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.5 | 3.1 | GO:0030425 | dendrite(GO:0030425) |
0.5 | 3.1 | GO:0043005 | neuron projection(GO:0043005) |
0.5 | 22.5 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.5 | 1.5 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.5 | 29.8 | GO:0005581 | collagen trimer(GO:0005581) |
0.5 | 3.0 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.5 | 6.0 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.5 | 1.0 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.5 | 8.5 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.5 | 2.5 | GO:0000796 | condensin complex(GO:0000796) |
0.5 | 1.5 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.5 | 0.5 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.5 | 2.9 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.5 | 2.9 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.5 | 29.4 | GO:0005814 | centriole(GO:0005814) |
0.5 | 0.5 | GO:0071010 | prespliceosome(GO:0071010) |
0.5 | 0.5 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.5 | 0.5 | GO:0005683 | U7 snRNP(GO:0005683) |
0.5 | 0.5 | GO:0071437 | invadopodium(GO:0071437) |
0.5 | 1.4 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.5 | 2.3 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.5 | 20.4 | GO:0005604 | basement membrane(GO:0005604) |
0.5 | 4.6 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.5 | 79.4 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.5 | 27.5 | GO:0030427 | site of polarized growth(GO:0030427) |
0.5 | 1.4 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.5 | 1.8 | GO:0042581 | specific granule(GO:0042581) |
0.5 | 2.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.4 | 52.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.4 | 4.9 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.4 | 1.8 | GO:0005652 | nuclear lamina(GO:0005652) |
0.4 | 2.2 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.4 | 14.5 | GO:0045171 | intercellular bridge(GO:0045171) |
0.4 | 1.7 | GO:0030904 | retromer complex(GO:0030904) |
0.4 | 3.9 | GO:0031045 | dense core granule(GO:0031045) |
0.4 | 1.3 | GO:0090543 | Flemming body(GO:0090543) |
0.4 | 3.9 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.4 | 0.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.4 | 1.7 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.4 | 2.2 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.4 | 1.3 | GO:0038201 | TOR complex(GO:0038201) |
0.4 | 0.9 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.4 | 64.7 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.4 | 7.7 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.4 | 1.7 | GO:0097542 | ciliary tip(GO:0097542) |
0.4 | 0.4 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.4 | 1.7 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.4 | 10.8 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.4 | 0.4 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.4 | 1.7 | GO:0016363 | nuclear matrix(GO:0016363) |
0.4 | 2.1 | GO:0034709 | methylosome(GO:0034709) |
0.4 | 1.7 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.4 | 5.4 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.4 | 0.4 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.4 | 6.1 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.4 | 13.9 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.4 | 1.2 | GO:0097470 | ribbon synapse(GO:0097470) |
0.4 | 2.8 | GO:0005902 | microvillus(GO:0005902) |
0.4 | 2.0 | GO:1904949 | ATPase complex(GO:1904949) |
0.4 | 5.2 | GO:0031519 | PcG protein complex(GO:0031519) |
0.4 | 9.1 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.4 | 0.8 | GO:0016272 | prefoldin complex(GO:0016272) |
0.4 | 1.5 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.4 | 7.7 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.4 | 2.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.4 | 10.0 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.4 | 0.8 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.4 | 0.4 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.4 | 7.9 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.4 | 4.9 | GO:0034707 | chloride channel complex(GO:0034707) |
0.4 | 2.6 | GO:0032426 | stereocilium tip(GO:0032426) |
0.4 | 4.1 | GO:0070161 | anchoring junction(GO:0070161) |
0.4 | 1.1 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.4 | 1.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.4 | 15.1 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.4 | 4.4 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.4 | 0.4 | GO:0031313 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.4 | 3.3 | GO:0005771 | multivesicular body(GO:0005771) |
0.4 | 1.4 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.4 | 1.4 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.4 | 3.2 | GO:0010369 | chromocenter(GO:0010369) |
0.4 | 0.4 | GO:0002141 | stereocilia ankle link(GO:0002141) USH2 complex(GO:1990696) |
0.4 | 13.3 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.4 | 12.2 | GO:0036064 | ciliary basal body(GO:0036064) |
0.4 | 0.4 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.4 | 1.8 | GO:0000801 | central element(GO:0000801) |
0.4 | 14.5 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.4 | 12.7 | GO:0043195 | terminal bouton(GO:0043195) |
0.3 | 1.4 | GO:0089701 | U2AF(GO:0089701) |
0.3 | 0.3 | GO:0001650 | fibrillar center(GO:0001650) |
0.3 | 3.4 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.3 | 1.7 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.3 | 71.3 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.3 | 11.1 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.3 | 25.6 | GO:0005769 | early endosome(GO:0005769) |
0.3 | 0.7 | GO:0070469 | respiratory chain(GO:0070469) |
0.3 | 2.0 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.3 | 210.3 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.3 | 45.4 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.3 | 0.3 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.3 | 0.6 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.3 | 0.6 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.3 | 7.9 | GO:0032040 | small-subunit processome(GO:0032040) |
0.3 | 1.3 | GO:0032420 | stereocilium(GO:0032420) |
0.3 | 0.9 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.3 | 0.9 | GO:0000125 | PCAF complex(GO:0000125) |
0.3 | 3.7 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.3 | 3.1 | GO:0072562 | blood microparticle(GO:0072562) |
0.3 | 0.9 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.3 | 3.3 | GO:0043209 | myelin sheath(GO:0043209) |
0.3 | 1.8 | GO:0042382 | paraspeckles(GO:0042382) |
0.3 | 3.9 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.3 | 0.9 | GO:0033202 | DNA helicase complex(GO:0033202) |
0.3 | 1.5 | GO:0033270 | paranode region of axon(GO:0033270) |
0.3 | 1570.3 | GO:0005737 | cytoplasm(GO:0005737) |
0.3 | 19.3 | GO:0030054 | cell junction(GO:0030054) |
0.3 | 27.7 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.3 | 1.4 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.3 | 1.1 | GO:0031982 | vesicle(GO:0031982) |
0.3 | 0.3 | GO:0031523 | Myb complex(GO:0031523) |
0.3 | 26.2 | GO:0043235 | receptor complex(GO:0043235) |
0.3 | 0.5 | GO:0001652 | granular component(GO:0001652) |
0.3 | 0.5 | GO:0001520 | outer dense fiber(GO:0001520) |
0.3 | 0.8 | GO:0030914 | STAGA complex(GO:0030914) |
0.3 | 136.1 | GO:0070062 | extracellular exosome(GO:0070062) |
0.3 | 0.8 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.3 | 25.3 | GO:0005856 | cytoskeleton(GO:0005856) |
0.3 | 0.3 | GO:0044292 | dendrite terminus(GO:0044292) |
0.2 | 0.5 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.2 | 0.5 | GO:1990130 | Iml1 complex(GO:1990130) |
0.2 | 5.7 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.2 | 0.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 1.5 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.2 | 87.9 | GO:0044421 | extracellular region part(GO:0044421) |
0.2 | 4.4 | GO:0012505 | endomembrane system(GO:0012505) |
0.2 | 1.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.2 | 0.7 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.2 | 1.1 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
0.2 | 0.2 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.2 | 21.1 | GO:0005667 | transcription factor complex(GO:0005667) |
0.2 | 0.8 | GO:0031252 | cell leading edge(GO:0031252) |
0.2 | 0.2 | GO:0098862 | cluster of actin-based cell projections(GO:0098862) |
0.2 | 1.2 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.2 | 0.2 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.2 | 3.7 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 9.6 | GO:0098552 | side of membrane(GO:0098552) |
0.1 | 359.1 | GO:0016021 | integral component of membrane(GO:0016021) |
0.1 | 27.9 | GO:0016020 | membrane(GO:0016020) |
0.1 | 0.7 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 3.1 | GO:0009986 | cell surface(GO:0009986) |
0.1 | 1.2 | GO:0005929 | cilium(GO:0005929) |
0.1 | 0.1 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.1 | 3.1 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.1 | 0.7 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.2 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 0.1 | GO:0045177 | apical part of cell(GO:0045177) |
0.1 | 0.2 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 0.2 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 0.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 0.2 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 0.5 | GO:0070461 | SAGA complex(GO:0000124) SAGA-type complex(GO:0070461) |
0.1 | 0.1 | GO:1990423 | RZZ complex(GO:1990423) |
0.1 | 21.4 | GO:0005576 | extracellular region(GO:0005576) |
0.1 | 90.8 | GO:0044464 | cell part(GO:0044464) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
30.9 | 123.4 | GO:0031433 | telethonin binding(GO:0031433) |
18.5 | 55.6 | GO:0051373 | FATZ binding(GO:0051373) |
10.5 | 31.5 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
8.1 | 24.3 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
6.9 | 27.5 | GO:0031013 | troponin I binding(GO:0031013) |
6.8 | 47.9 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
6.6 | 19.7 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
6.5 | 58.1 | GO:0034817 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
6.4 | 57.9 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
6.4 | 19.3 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
5.8 | 35.0 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
5.8 | 34.8 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
5.8 | 29.0 | GO:0004111 | creatine kinase activity(GO:0004111) |
5.7 | 34.1 | GO:0031432 | titin binding(GO:0031432) |
5.6 | 33.6 | GO:0043559 | insulin binding(GO:0043559) |
5.4 | 16.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
5.3 | 15.9 | GO:0070538 | oleic acid binding(GO:0070538) |
4.9 | 14.6 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
4.9 | 43.7 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
4.8 | 19.4 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
4.5 | 9.0 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
4.5 | 13.4 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
4.3 | 21.5 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
4.1 | 12.3 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
3.8 | 57.1 | GO:0005521 | lamin binding(GO:0005521) |
3.7 | 55.0 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
3.6 | 61.7 | GO:0043274 | phospholipase binding(GO:0043274) |
3.6 | 64.5 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
3.6 | 46.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
3.5 | 31.9 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
3.5 | 17.6 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
3.5 | 13.8 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
3.4 | 10.3 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
3.3 | 20.1 | GO:0018499 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
3.3 | 23.0 | GO:0070736 | UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligase activity(GO:0008766) ribosomal S6-glutamic acid ligase activity(GO:0018169) coenzyme F420-0 gamma-glutamyl ligase activity(GO:0043773) coenzyme F420-2 alpha-glutamyl ligase activity(GO:0043774) protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) protein-glycine ligase activity, elongating(GO:0070737) tubulin-glycine ligase activity(GO:0070738) |
3.2 | 19.4 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
3.2 | 3.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
3.0 | 3.0 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
3.0 | 12.0 | GO:0071253 | connexin binding(GO:0071253) |
3.0 | 56.1 | GO:0003785 | actin monomer binding(GO:0003785) |
2.9 | 8.6 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
2.8 | 30.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
2.7 | 32.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
2.7 | 8.2 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
2.7 | 10.7 | GO:0016018 | cyclosporin A binding(GO:0016018) |
2.6 | 26.5 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
2.6 | 5.2 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
2.6 | 7.8 | GO:0004967 | glucagon receptor activity(GO:0004967) |
2.6 | 20.7 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
2.6 | 7.7 | GO:0051525 | NFAT protein binding(GO:0051525) |
2.6 | 15.4 | GO:0001727 | lipid kinase activity(GO:0001727) |
2.6 | 12.8 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
2.5 | 25.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
2.5 | 7.6 | GO:0055100 | adiponectin binding(GO:0055100) |
2.5 | 7.5 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
2.5 | 17.2 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
2.4 | 7.3 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
2.4 | 50.8 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
2.4 | 7.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
2.4 | 28.5 | GO:0031005 | filamin binding(GO:0031005) |
2.4 | 18.8 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
2.4 | 18.8 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
2.3 | 7.0 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
2.3 | 126.3 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
2.3 | 21.0 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
2.3 | 16.2 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
2.3 | 4.6 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
2.3 | 39.1 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
2.2 | 13.5 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
2.2 | 11.0 | GO:0043495 | protein anchor(GO:0043495) |
2.2 | 32.8 | GO:0004857 | enzyme inhibitor activity(GO:0004857) |
2.2 | 8.8 | GO:0098821 | BMP receptor activity(GO:0098821) |
2.2 | 8.6 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
2.1 | 6.4 | GO:0036033 | mediator complex binding(GO:0036033) |
2.1 | 27.5 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
2.1 | 6.3 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
2.1 | 35.4 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
2.0 | 4.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
2.0 | 8.2 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
2.0 | 8.1 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
2.0 | 6.1 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
2.0 | 6.1 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
2.0 | 16.1 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
2.0 | 4.0 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
2.0 | 6.0 | GO:0035514 | DNA demethylase activity(GO:0035514) |
2.0 | 28.2 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
2.0 | 35.2 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
1.9 | 7.6 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
1.9 | 5.7 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
1.9 | 18.9 | GO:0044548 | S100 protein binding(GO:0044548) |
1.9 | 9.4 | GO:0016530 | metallochaperone activity(GO:0016530) |
1.9 | 3.8 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
1.9 | 5.6 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) poly(U) RNA binding(GO:0008266) |
1.9 | 27.9 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
1.9 | 5.6 | GO:0050692 | DBD domain binding(GO:0050692) |
1.8 | 5.5 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
1.8 | 16.3 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
1.8 | 5.4 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
1.8 | 3.6 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
1.8 | 5.4 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
1.8 | 7.2 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
1.8 | 5.4 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
1.8 | 3.5 | GO:0032027 | myosin light chain binding(GO:0032027) |
1.7 | 1.7 | GO:0051425 | PTB domain binding(GO:0051425) |
1.7 | 20.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
1.7 | 6.9 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
1.7 | 8.6 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
1.7 | 1.7 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
1.7 | 1.7 | GO:1990715 | mRNA CDS binding(GO:1990715) |
1.7 | 8.5 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
1.7 | 11.7 | GO:1990459 | transferrin receptor binding(GO:1990459) |
1.7 | 1.7 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
1.7 | 10.0 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
1.6 | 4.9 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
1.6 | 42.1 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
1.6 | 4.8 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
1.6 | 1.6 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
1.6 | 7.9 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
1.6 | 10.9 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
1.6 | 4.7 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
1.5 | 23.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
1.5 | 10.8 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.5 | 13.9 | GO:0005523 | tropomyosin binding(GO:0005523) |
1.5 | 18.4 | GO:0005243 | gap junction channel activity(GO:0005243) |
1.5 | 6.1 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
1.5 | 7.6 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
1.5 | 16.7 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
1.5 | 6.1 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
1.5 | 7.6 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
1.5 | 19.5 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
1.5 | 7.5 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
1.5 | 7.5 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
1.5 | 12.0 | GO:0003993 | acid phosphatase activity(GO:0003993) |
1.5 | 1.5 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
1.5 | 17.7 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
1.5 | 11.8 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
1.5 | 20.5 | GO:0005542 | folic acid binding(GO:0005542) |
1.4 | 17.4 | GO:0004707 | MAP kinase activity(GO:0004707) |
1.4 | 5.8 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
1.4 | 2.9 | GO:0019961 | interferon binding(GO:0019961) |
1.4 | 11.3 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
1.4 | 4.2 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
1.4 | 2.8 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
1.4 | 29.0 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
1.4 | 34.5 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
1.4 | 42.8 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
1.4 | 5.5 | GO:1904288 | BAT3 complex binding(GO:1904288) |
1.4 | 106.7 | GO:0051015 | actin filament binding(GO:0051015) |
1.4 | 70.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
1.4 | 4.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
1.4 | 12.2 | GO:0003713 | transcription coactivator activity(GO:0003713) |
1.4 | 4.1 | GO:0005522 | profilin binding(GO:0005522) |
1.3 | 2.7 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
1.3 | 2.7 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
1.3 | 5.3 | GO:0070412 | R-SMAD binding(GO:0070412) |
1.3 | 5.3 | GO:0051434 | BH3 domain binding(GO:0051434) |
1.3 | 4.0 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
1.3 | 66.0 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
1.3 | 3.9 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
1.3 | 56.6 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
1.3 | 41.1 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
1.3 | 5.1 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
1.3 | 3.8 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
1.3 | 6.3 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
1.3 | 3.8 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
1.3 | 22.6 | GO:0042805 | actinin binding(GO:0042805) |
1.3 | 3.8 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
1.2 | 6.2 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
1.2 | 7.5 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
1.2 | 4.9 | GO:0043426 | MRF binding(GO:0043426) |
1.2 | 3.7 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
1.2 | 4.9 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
1.2 | 3.7 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
1.2 | 18.4 | GO:0030371 | translation repressor activity(GO:0030371) |
1.2 | 3.7 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
1.2 | 3.7 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
1.2 | 7.3 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
1.2 | 1.2 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
1.2 | 8.5 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
1.2 | 7.3 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
1.2 | 2.4 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
1.2 | 1.2 | GO:0043398 | HLH domain binding(GO:0043398) |
1.2 | 2.4 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
1.2 | 1.2 | GO:0030911 | TPR domain binding(GO:0030911) |
1.2 | 3.5 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
1.2 | 30.5 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
1.2 | 8.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
1.2 | 3.5 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
1.2 | 3.5 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
1.2 | 2.3 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
1.2 | 4.6 | GO:0048495 | Roundabout binding(GO:0048495) |
1.2 | 3.5 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
1.2 | 6.9 | GO:0005536 | glucose binding(GO:0005536) |
1.1 | 2.3 | GO:0004386 | helicase activity(GO:0004386) |
1.1 | 3.4 | GO:1990239 | steroid hormone binding(GO:1990239) |
1.1 | 3.4 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
1.1 | 3.4 | GO:0035939 | microsatellite binding(GO:0035939) |
1.1 | 9.0 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
1.1 | 40.3 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
1.1 | 3.4 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
1.1 | 10.0 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
1.1 | 1.1 | GO:0015081 | sodium ion transmembrane transporter activity(GO:0015081) |
1.1 | 3.3 | GO:0070878 | primary miRNA binding(GO:0070878) |
1.1 | 4.4 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
1.1 | 2.2 | GO:0004771 | sterol esterase activity(GO:0004771) |
1.1 | 7.6 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
1.1 | 9.7 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
1.1 | 3.2 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
1.1 | 22.7 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
1.1 | 3.2 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
1.1 | 1.1 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
1.1 | 197.2 | GO:0003779 | actin binding(GO:0003779) |
1.1 | 3.2 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
1.1 | 5.3 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
1.1 | 3.2 | GO:0070698 | type I activin receptor binding(GO:0070698) |
1.1 | 27.5 | GO:0001968 | fibronectin binding(GO:0001968) |
1.1 | 9.5 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
1.0 | 6.3 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
1.0 | 4.2 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
1.0 | 4.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
1.0 | 3.1 | GO:0034711 | inhibin binding(GO:0034711) |
1.0 | 4.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
1.0 | 3.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
1.0 | 4.1 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
1.0 | 9.1 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
1.0 | 5.0 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
1.0 | 3.0 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
1.0 | 2.0 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.0 | 7.0 | GO:0034071 | cobinamide kinase activity(GO:0008819) phytol kinase activity(GO:0010276) phenol kinase activity(GO:0018720) cyclin-dependent protein kinase activating kinase regulator activity(GO:0019914) inositol tetrakisphosphate 2-kinase activity(GO:0032942) heptose 7-phosphate kinase activity(GO:0033785) aminoglycoside phosphotransferase activity(GO:0034071) eukaryotic elongation factor-2 kinase regulator activity(GO:0042556) eukaryotic elongation factor-2 kinase activator activity(GO:0042557) LPPG:FO 2-phospho-L-lactate transferase activity(GO:0043743) cytidine kinase activity(GO:0043771) glycerate 2-kinase activity(GO:0043798) (S)-lactate 2-kinase activity(GO:0043841) phosphoserine:homoserine phosphotransferase activity(GO:0043899) L-seryl-tRNA(Sec) kinase activity(GO:0043915) phosphocholine transferase activity(GO:0044605) GTP-dependent polynucleotide kinase activity(GO:0051735) farnesol kinase activity(GO:0052668) CTP:2-trans,-6-trans-farnesol kinase activity(GO:0052669) geraniol kinase activity(GO:0052670) geranylgeraniol kinase activity(GO:0052671) CTP:geranylgeraniol kinase activity(GO:0052672) prenol kinase activity(GO:0052673) 1-phosphatidylinositol-5-kinase activity(GO:0052810) 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
1.0 | 1.0 | GO:0070034 | telomerase RNA binding(GO:0070034) |
1.0 | 3.0 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
1.0 | 18.7 | GO:0043236 | laminin binding(GO:0043236) |
1.0 | 7.8 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
1.0 | 32.2 | GO:0017046 | peptide hormone binding(GO:0017046) |
1.0 | 9.7 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
1.0 | 3.9 | GO:0019992 | diacylglycerol binding(GO:0019992) |
1.0 | 31.6 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
1.0 | 2.9 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
1.0 | 5.7 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.9 | 8.5 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.9 | 2.8 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.9 | 0.9 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.9 | 8.5 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.9 | 4.7 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.9 | 5.6 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.9 | 5.6 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.9 | 2.8 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.9 | 25.1 | GO:0044325 | ion channel binding(GO:0044325) |
0.9 | 7.4 | GO:0038191 | neuropilin binding(GO:0038191) |
0.9 | 3.7 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.9 | 6.5 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.9 | 5.5 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.9 | 3.7 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.9 | 3.7 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.9 | 16.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.9 | 4.5 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.9 | 2.7 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.9 | 4.5 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.9 | 9.8 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.9 | 11.5 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.9 | 34.3 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.9 | 1.8 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.9 | 10.4 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.9 | 2.6 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.9 | 2.6 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.9 | 0.9 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.9 | 4.3 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.9 | 32.5 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.8 | 4.2 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.8 | 2.5 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.8 | 2.5 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.8 | 0.8 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.8 | 3.4 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.8 | 15.2 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.8 | 5.1 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.8 | 5.0 | GO:0003680 | AT DNA binding(GO:0003680) |
0.8 | 9.2 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.8 | 5.8 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.8 | 2.5 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.8 | 4.1 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.8 | 4.9 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.8 | 4.1 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.8 | 3.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.8 | 2.4 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.8 | 4.1 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.8 | 6.4 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.8 | 3.2 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.8 | 2.4 | GO:0015232 | heme transporter activity(GO:0015232) |
0.8 | 1.6 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.8 | 7.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.8 | 2.4 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.8 | 2.4 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.8 | 7.9 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.8 | 3.1 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
0.8 | 17.2 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.8 | 2.3 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.8 | 3.1 | GO:0003774 | motor activity(GO:0003774) |
0.8 | 6.2 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.8 | 3.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.8 | 267.7 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.8 | 0.8 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.8 | 3.8 | GO:0017040 | ceramidase activity(GO:0017040) |
0.8 | 3.1 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.8 | 18.4 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.8 | 4.6 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.8 | 3.0 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.7 | 3.0 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.7 | 15.7 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.7 | 20.2 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.7 | 35.6 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.7 | 2.2 | GO:0030519 | snoRNP binding(GO:0030519) |
0.7 | 0.7 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.7 | 1.5 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.7 | 11.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.7 | 13.1 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.7 | 8.7 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.7 | 2.9 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.7 | 2.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.7 | 9.3 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.7 | 2.1 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.7 | 3.5 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.7 | 19.1 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.7 | 0.7 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.7 | 7.7 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.7 | 2.8 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.7 | 4.2 | GO:0016595 | glutamate binding(GO:0016595) |
0.7 | 13.9 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.7 | 2.1 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.7 | 0.7 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
0.7 | 1.4 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.7 | 1.4 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.7 | 4.7 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.7 | 2.0 | GO:0070728 | leucine binding(GO:0070728) |
0.7 | 3.4 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.7 | 2.0 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.7 | 1.3 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.7 | 6.0 | GO:0070628 | proteasome binding(GO:0070628) |
0.7 | 12.5 | GO:0030552 | cAMP binding(GO:0030552) |
0.7 | 1.3 | GO:0043199 | sulfate binding(GO:0043199) |
0.7 | 2.0 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.7 | 11.2 | GO:0031489 | myosin V binding(GO:0031489) |
0.7 | 4.6 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.7 | 19.7 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.7 | 2.0 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.7 | 2.6 | GO:0009374 | biotin binding(GO:0009374) |
0.7 | 2.0 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.7 | 5.9 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.7 | 1.3 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.7 | 0.7 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.6 | 1.3 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.6 | 7.1 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.6 | 9.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.6 | 6.4 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.6 | 1.3 | GO:0005534 | galactose binding(GO:0005534) |
0.6 | 38.6 | GO:0005178 | integrin binding(GO:0005178) |
0.6 | 3.8 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.6 | 2.5 | GO:0045502 | dynein binding(GO:0045502) |
0.6 | 6.9 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.6 | 1.9 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.6 | 7.5 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.6 | 13.6 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.6 | 5.5 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.6 | 111.3 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.6 | 2.5 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.6 | 9.8 | GO:0005112 | Notch binding(GO:0005112) |
0.6 | 11.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.6 | 4.9 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.6 | 34.5 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.6 | 25.4 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.6 | 1.8 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.6 | 10.8 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.6 | 1.2 | GO:0016151 | nickel cation binding(GO:0016151) |
0.6 | 3.6 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.6 | 0.6 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
0.6 | 4.8 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.6 | 7.2 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.6 | 29.2 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.6 | 0.6 | GO:0015927 | trehalase activity(GO:0015927) |
0.6 | 7.1 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.6 | 4.2 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.6 | 2.4 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.6 | 2.9 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.6 | 16.4 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.6 | 1.8 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.6 | 4.1 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.6 | 1.2 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.6 | 2.3 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.6 | 6.3 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.6 | 6.8 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.6 | 16.5 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.6 | 0.6 | GO:0019862 | IgA binding(GO:0019862) |
0.6 | 1.7 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.6 | 9.0 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.6 | 2.2 | GO:0034416 | bisphosphoglycerate 2-phosphatase activity(GO:0004083) bisphosphoglycerate phosphatase activity(GO:0034416) |
0.6 | 0.6 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.6 | 1.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.6 | 4.4 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.6 | 1.7 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.6 | 3.9 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.6 | 1.7 | GO:0016015 | morphogen activity(GO:0016015) |
0.5 | 71.4 | GO:0005543 | phospholipid binding(GO:0005543) |
0.5 | 4.9 | GO:0003796 | lysozyme activity(GO:0003796) |
0.5 | 2.2 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.5 | 4.9 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.5 | 12.0 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.5 | 38.5 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.5 | 1.6 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.5 | 7.0 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.5 | 5.4 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.5 | 1.6 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.5 | 1.6 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.5 | 1.1 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.5 | 1.6 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.5 | 2.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.5 | 0.5 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.5 | 6.9 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.5 | 2.1 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.5 | 2.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.5 | 2.1 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.5 | 8.9 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.5 | 6.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.5 | 0.5 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.5 | 2.1 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.5 | 3.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.5 | 2.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.5 | 1.5 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.5 | 1.0 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.5 | 1.0 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.5 | 1.0 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.5 | 4.5 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.5 | 9.5 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.5 | 1.5 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.5 | 5.9 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.5 | 3.5 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.5 | 11.3 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.5 | 1.5 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.5 | 12.8 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.5 | 3.9 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.5 | 1.5 | GO:0000182 | rDNA binding(GO:0000182) |
0.5 | 3.4 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.5 | 1.5 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.5 | 14.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.5 | 1.9 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.5 | 1.0 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.5 | 1.9 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.5 | 10.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.5 | 13.4 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.5 | 6.2 | GO:0070888 | E-box binding(GO:0070888) |
0.5 | 2.4 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.5 | 4.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.5 | 1.4 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.5 | 15.9 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.5 | 1.9 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.5 | 1.9 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.5 | 1.4 | GO:0004103 | choline kinase activity(GO:0004103) |
0.5 | 14.8 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.5 | 1.8 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.5 | 4.1 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.5 | 2.3 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.5 | 1.8 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.5 | 3.6 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.5 | 0.9 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.5 | 16.2 | GO:0005516 | calmodulin binding(GO:0005516) |
0.4 | 1.8 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.4 | 5.8 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.4 | 1.3 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.4 | 1.8 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.4 | 4.0 | GO:0008759 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
0.4 | 2.2 | GO:0016936 | galactoside binding(GO:0016936) |
0.4 | 3.6 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.4 | 1.3 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.4 | 36.7 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
0.4 | 1.8 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.4 | 6.6 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.4 | 3.9 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.4 | 1.3 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.4 | 1.3 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.4 | 17.7 | GO:0044823 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.4 | 0.4 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.4 | 2.2 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.4 | 0.4 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.4 | 0.4 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.4 | 0.9 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.4 | 2.1 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.4 | 3.8 | GO:0004568 | chitinase activity(GO:0004568) |
0.4 | 0.8 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.4 | 0.8 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.4 | 0.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.4 | 1.3 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.4 | 1.3 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.4 | 1.3 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.4 | 0.8 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.4 | 2.1 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.4 | 2.5 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.4 | 1.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.4 | 1.6 | GO:0035671 | enone reductase activity(GO:0035671) |
0.4 | 0.8 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.4 | 1.2 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.4 | 2.0 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.4 | 0.4 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.4 | 3.6 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.4 | 2.0 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.4 | 14.0 | GO:0019003 | GDP binding(GO:0019003) |
0.4 | 0.4 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.4 | 0.4 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.4 | 6.7 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.4 | 0.4 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.4 | 2.3 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.4 | 12.9 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.4 | 47.0 | GO:0015631 | tubulin binding(GO:0015631) |
0.4 | 4.6 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.4 | 130.4 | GO:0005509 | calcium ion binding(GO:0005509) |
0.4 | 1.9 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.4 | 1.1 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.4 | 0.4 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.4 | 3.8 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.4 | 26.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.4 | 4.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.4 | 1.1 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.4 | 0.7 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.4 | 2.6 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.4 | 1.9 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.4 | 0.4 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.4 | 17.3 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.4 | 2.2 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.4 | 2.2 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.4 | 1.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.4 | 19.2 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.4 | 4.7 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.4 | 0.7 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.4 | 1.4 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.4 | 0.7 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.4 | 4.6 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.4 | 2.5 | GO:0016779 | nucleotidyltransferase activity(GO:0016779) |
0.4 | 1.4 | GO:0010851 | cyclase regulator activity(GO:0010851) guanylate cyclase regulator activity(GO:0030249) |
0.4 | 1.8 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.4 | 1.1 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.4 | 1.1 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.4 | 0.7 | GO:0090079 | translation activator activity(GO:0008494) translation regulator activity, nucleic acid binding(GO:0090079) |
0.4 | 3.9 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.4 | 4.6 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.3 | 5.9 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.3 | 8.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.3 | 1.0 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.3 | 5.5 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.3 | 2.4 | GO:0005272 | sodium channel activity(GO:0005272) |
0.3 | 0.3 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.3 | 1.0 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.3 | 0.7 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.3 | 0.7 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.3 | 1.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.3 | 4.4 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.3 | 0.7 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.3 | 4.0 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.3 | 8.7 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.3 | 10.3 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.3 | 0.7 | GO:0050051 | alkane 1-monooxygenase activity(GO:0018685) leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.3 | 8.2 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.3 | 1.6 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.3 | 3.6 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.3 | 8.5 | GO:0002039 | p53 binding(GO:0002039) |
0.3 | 1.0 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.3 | 2.6 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.3 | 2.3 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.3 | 10.0 | GO:0005244 | voltage-gated ion channel activity(GO:0005244) voltage-gated channel activity(GO:0022832) |
0.3 | 1.3 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.3 | 0.3 | GO:0002060 | nucleobase binding(GO:0002054) purine nucleobase binding(GO:0002060) |
0.3 | 1.0 | GO:2001069 | glycogen binding(GO:2001069) |
0.3 | 1.3 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.3 | 1.6 | GO:0030515 | snoRNA binding(GO:0030515) |
0.3 | 4.1 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.3 | 0.3 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.3 | 0.3 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.3 | 0.6 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.3 | 1.2 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.3 | 0.6 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.3 | 0.6 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.3 | 1.9 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.3 | 0.3 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.3 | 0.9 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.3 | 2.7 | GO:0030276 | clathrin binding(GO:0030276) |
0.3 | 2.1 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.3 | 6.0 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.3 | 0.6 | GO:0071814 | lipoprotein particle binding(GO:0071813) protein-lipid complex binding(GO:0071814) |
0.3 | 3.0 | GO:0070402 | NADPH binding(GO:0070402) |
0.3 | 0.3 | GO:0070052 | collagen V binding(GO:0070052) |
0.3 | 2.1 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.3 | 4.2 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.3 | 8.0 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.3 | 2.1 | GO:0005123 | death receptor binding(GO:0005123) |
0.3 | 2.9 | GO:0042562 | hormone binding(GO:0042562) |
0.3 | 0.3 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.3 | 7.9 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.3 | 0.6 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.3 | 0.6 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.3 | 20.6 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.3 | 0.3 | GO:0016849 | phosphorus-oxygen lyase activity(GO:0016849) |
0.3 | 0.3 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.3 | 1.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.3 | 0.8 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.3 | 0.3 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.3 | 0.8 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.3 | 1.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.3 | 1.1 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.3 | 29.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.3 | 8.5 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.3 | 1.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.3 | 0.8 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.3 | 0.3 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
0.3 | 1.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.3 | 0.8 | GO:0070403 | NAD+ binding(GO:0070403) |
0.3 | 0.5 | GO:0008199 | ferric iron binding(GO:0008199) |
0.3 | 0.5 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.3 | 2.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.3 | 4.0 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.3 | 3.5 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.3 | 0.8 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.3 | 0.8 | GO:1904680 | peptide transmembrane transporter activity(GO:1904680) |
0.3 | 2.4 | GO:0019841 | retinol binding(GO:0019841) |
0.3 | 0.3 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.3 | 0.8 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.3 | 0.8 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.3 | 105.9 | GO:0008270 | zinc ion binding(GO:0008270) |
0.3 | 0.5 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.3 | 1.3 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.3 | 0.8 | GO:0050733 | RS domain binding(GO:0050733) |
0.3 | 10.1 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.3 | 0.8 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.3 | 45.1 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.3 | 4.1 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.3 | 0.8 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.3 | 0.8 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.3 | 1.8 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.3 | 0.3 | GO:0070905 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) serine binding(GO:0070905) |
0.3 | 4.3 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.3 | 2.0 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.3 | 0.3 | GO:0035197 | siRNA binding(GO:0035197) |
0.3 | 0.8 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.3 | 1.8 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.3 | 0.8 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.3 | 0.8 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.3 | 1.5 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.2 | 0.5 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.2 | 1.7 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.2 | 25.7 | GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity(GO:0008757) |
0.2 | 0.7 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.2 | 0.5 | GO:0030275 | LRR domain binding(GO:0030275) |
0.2 | 0.7 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.2 | 2.2 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.2 | 11.6 | GO:0042393 | histone binding(GO:0042393) |
0.2 | 0.5 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.2 | 1.4 | GO:0017022 | myosin binding(GO:0017022) |
0.2 | 0.5 | GO:0034584 | piRNA binding(GO:0034584) |
0.2 | 4.7 | GO:0015485 | cholesterol binding(GO:0015485) |
0.2 | 0.7 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.2 | 0.9 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.2 | 2.0 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.2 | 0.2 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.2 | 1.4 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.2 | 1.8 | GO:0004953 | icosanoid receptor activity(GO:0004953) |
0.2 | 1.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 0.4 | GO:0070061 | fructose binding(GO:0070061) |
0.2 | 6.4 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.2 | 0.2 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.2 | 0.2 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.2 | 26.1 | GO:0008047 | enzyme activator activity(GO:0008047) |
0.2 | 0.7 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.2 | 0.4 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.2 | 35.6 | GO:0005525 | GTP binding(GO:0005525) |
0.2 | 0.7 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.2 | 10.7 | GO:0008565 | protein transporter activity(GO:0008565) |
0.2 | 16.1 | GO:0031267 | small GTPase binding(GO:0031267) |
0.2 | 0.9 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.2 | 56.5 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.2 | 0.4 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.2 | 19.5 | GO:0005179 | hormone activity(GO:0005179) |
0.2 | 0.4 | GO:0046790 | virion binding(GO:0046790) |
0.2 | 0.6 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.2 | 2.9 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.2 | 2.0 | GO:0022842 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.2 | 0.8 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.2 | 0.4 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 0.2 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.2 | 0.2 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.2 | 0.8 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 0.6 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.2 | 1.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 2.0 | GO:0035326 | enhancer binding(GO:0035326) |
0.2 | 1.4 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.2 | 0.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.2 | 3.5 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.2 | 0.4 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.2 | 0.4 | GO:0004527 | exonuclease activity(GO:0004527) |
0.2 | 0.2 | GO:0008061 | chitin binding(GO:0008061) |
0.2 | 23.9 | GO:0019901 | protein kinase binding(GO:0019901) |
0.2 | 2.1 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.2 | 1.3 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.2 | 1.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.2 | 0.6 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.2 | 2.3 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.2 | 0.7 | GO:0016684 | peroxidase activity(GO:0004601) oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.2 | 2.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.2 | 0.2 | GO:0070840 | dynein complex binding(GO:0070840) |
0.2 | 3.6 | GO:0008144 | drug binding(GO:0008144) |
0.2 | 5.9 | GO:0004713 | protein tyrosine kinase activity(GO:0004713) |
0.2 | 0.4 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 19.1 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.2 | 1.4 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.2 | 0.7 | GO:0034889 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.2 | 18.5 | GO:0004672 | protein kinase activity(GO:0004672) |
0.2 | 0.5 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.2 | 3.2 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.2 | 1.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.2 | 0.5 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 6.4 | GO:0008201 | heparin binding(GO:0008201) |
0.2 | 1.3 | GO:0015928 | fucosidase activity(GO:0015928) |
0.2 | 2.0 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.2 | 0.3 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.2 | 1.8 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.2 | 0.2 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.2 | 0.2 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.2 | 1.4 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.2 | 4.0 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.2 | 2.5 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.2 | 0.5 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.2 | 1.3 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.2 | 0.2 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.2 | 0.9 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.2 | 2.4 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 0.2 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 1.9 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 0.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.1 | 2.9 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.6 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 1.4 | GO:0016247 | channel regulator activity(GO:0016247) |
0.1 | 0.6 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 0.1 | GO:0001047 | core promoter binding(GO:0001047) |
0.1 | 0.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 0.3 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.3 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.3 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.1 | 0.1 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.1 | 3.1 | GO:0070851 | growth factor receptor binding(GO:0070851) |
0.1 | 0.4 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 0.3 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 0.1 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 0.4 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.8 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.1 | 0.1 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 1.7 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 0.5 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.1 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 0.8 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.1 | 0.8 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 1.0 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 0.5 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.1 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.1 | 0.4 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 0.2 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 0.5 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.4 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.1 | 12.7 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.1 | 0.7 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 0.2 | GO:0018857 | acyl-CoA ligase activity(GO:0003996) succinate-CoA ligase activity(GO:0004774) 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.1 | 1.4 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 0.6 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.7 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 0.1 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 0.6 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.2 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.9 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.7 | GO:0008933 | lytic transglycosylase activity(GO:0008933) |
0.1 | 0.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 2.7 | GO:0003682 | chromatin binding(GO:0003682) |
0.1 | 69.9 | GO:0046872 | metal ion binding(GO:0046872) |
0.1 | 0.1 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 2.9 | GO:0061134 | peptidase regulator activity(GO:0061134) |
0.1 | 0.6 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 0.5 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.1 | GO:0018641 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.1 | 0.5 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.1 | 42.2 | GO:0042802 | identical protein binding(GO:0042802) |
0.1 | 1.0 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 1.8 | GO:0016903 | oxidoreductase activity, acting on the aldehyde or oxo group of donors(GO:0016903) |
0.1 | 0.3 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.1 | 0.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 0.2 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.1 | 0.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.6 | GO:0042277 | peptide binding(GO:0042277) |
0.1 | 0.1 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.1 | 0.3 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.4 | GO:0015265 | urea channel activity(GO:0015265) |
0.1 | 0.7 | GO:0015662 | ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism(GO:0015662) |
0.1 | 0.3 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.1 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.1 | 0.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 1.5 | GO:0016798 | hydrolase activity, acting on glycosyl bonds(GO:0016798) |
0.1 | 0.3 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.1 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 0.2 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 0.1 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.2 | GO:0072341 | modified amino acid binding(GO:0072341) |
0.1 | 0.1 | GO:0030545 | receptor regulator activity(GO:0030545) |
0.1 | 0.3 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.1 | 2.2 | GO:0000149 | SNARE binding(GO:0000149) |
0.1 | 0.3 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.5 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.1 | 1.4 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.9 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
0.1 | 14.9 | GO:0003677 | DNA binding(GO:0003677) |
0.1 | 0.2 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 0.1 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.1 | 0.1 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 3.4 | GO:0015293 | symporter activity(GO:0015293) |
0.1 | 1.3 | GO:0005496 | steroid binding(GO:0005496) |
0.1 | 0.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 0.1 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 0.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 0.1 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 26.7 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.1 | 0.1 | GO:0015298 | solute:cation antiporter activity(GO:0015298) |
0.1 | 5.3 | GO:0005198 | structural molecule activity(GO:0005198) |
0.1 | 0.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 1.6 | GO:0019887 | protein kinase regulator activity(GO:0019887) |
0.1 | 0.1 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 0.2 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.1 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.4 | GO:0005319 | lipid transporter activity(GO:0005319) |
0.1 | 1.5 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.1 | 0.1 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.1 | 0.4 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.4 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 0.1 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.1 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 79.0 | GO:0005515 | protein binding(GO:0005515) |
0.0 | 0.2 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.0 | 0.2 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.0 | 4.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.1 | GO:0048038 | quinone binding(GO:0048038) |
0.0 | 0.0 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 0.0 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.1 | GO:0004000 | adenosine deaminase activity(GO:0004000) hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.0 | 0.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.0 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.0 | 0.1 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.0 | 0.1 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.0 | 0.1 | GO:0015932 | nucleobase-containing compound transmembrane transporter activity(GO:0015932) |
0.0 | 0.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 24.9 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.0 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.0 | 0.0 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.0 | 0.0 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) |
0.0 | 0.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.0 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.0 | 0.0 | GO:0005267 | potassium channel activity(GO:0005267) |
0.0 | 0.0 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.0 | 0.1 | GO:0016917 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
0.0 | 0.0 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.0 | GO:0016594 | glycine binding(GO:0016594) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.4 | 83.7 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
2.8 | 44.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
2.7 | 5.3 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
2.6 | 28.6 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
2.5 | 35.0 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
2.2 | 46.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
2.0 | 87.7 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
2.0 | 70.4 | PID INSULIN PATHWAY | Insulin Pathway |
1.9 | 28.9 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
1.8 | 41.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
1.8 | 8.9 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
1.7 | 40.2 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
1.6 | 16.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
1.6 | 44.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
1.6 | 45.1 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
1.6 | 57.4 | PID ILK PATHWAY | Integrin-linked kinase signaling |
1.4 | 30.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
1.4 | 43.2 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
1.4 | 61.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
1.4 | 4.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
1.3 | 9.4 | PID IGF1 PATHWAY | IGF1 pathway |
1.3 | 13.1 | PID NECTIN PATHWAY | Nectin adhesion pathway |
1.3 | 60.0 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
1.3 | 49.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
1.3 | 7.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
1.3 | 64.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
1.2 | 14.9 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
1.2 | 8.5 | PID S1P S1P1 PATHWAY | S1P1 pathway |
1.2 | 9.6 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
1.2 | 15.5 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
1.1 | 15.6 | PID ARF 3PATHWAY | Arf1 pathway |
1.1 | 9.9 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
1.0 | 9.4 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
1.0 | 15.5 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
1.0 | 20.5 | PID RAS PATHWAY | Regulation of Ras family activation |
1.0 | 6.0 | PID IL3 PATHWAY | IL3-mediated signaling events |
1.0 | 9.7 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
1.0 | 2.9 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
1.0 | 11.6 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
1.0 | 15.2 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.9 | 8.5 | PID ALK2 PATHWAY | ALK2 signaling events |
0.9 | 15.1 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.9 | 4.6 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.9 | 29.6 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.9 | 0.9 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.9 | 33.8 | PID P53 REGULATION PATHWAY | p53 pathway |
0.9 | 29.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.8 | 20.2 | PID FGF PATHWAY | FGF signaling pathway |
0.8 | 36.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.8 | 9.2 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.8 | 6.7 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.8 | 2.5 | PID ALK1 PATHWAY | ALK1 signaling events |
0.8 | 18.0 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.8 | 9.0 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.8 | 4.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.8 | 4.0 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.8 | 11.0 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.8 | 12.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.8 | 12.3 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.8 | 8.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.8 | 1.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.7 | 16.3 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.7 | 8.9 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.7 | 18.4 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.7 | 3.7 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.7 | 10.9 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.7 | 21.6 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.7 | 4.2 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.7 | 14.5 | PID LKB1 PATHWAY | LKB1 signaling events |
0.6 | 12.2 | PID P73PATHWAY | p73 transcription factor network |
0.6 | 5.6 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.6 | 3.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.6 | 6.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.6 | 6.7 | PID ENDOTHELIN PATHWAY | Endothelins |
0.6 | 1.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.6 | 6.1 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.5 | 7.6 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.5 | 1.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.5 | 12.7 | PID AURORA B PATHWAY | Aurora B signaling |
0.5 | 13.2 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.5 | 10.4 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.5 | 18.7 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.5 | 5.1 | PID BCR 5PATHWAY | BCR signaling pathway |
0.5 | 2.6 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.5 | 15.5 | PID PLK1 PATHWAY | PLK1 signaling events |
0.5 | 3.9 | ST GAQ PATHWAY | G alpha q Pathway |
0.5 | 96.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.5 | 68.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.5 | 3.7 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.4 | 6.6 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.4 | 5.2 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.4 | 7.2 | PID BMP PATHWAY | BMP receptor signaling |
0.4 | 3.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.4 | 6.8 | PID ATM PATHWAY | ATM pathway |
0.4 | 1.7 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.4 | 9.5 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.4 | 0.8 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.4 | 1.5 | PID IFNG PATHWAY | IFN-gamma pathway |
0.4 | 1.9 | PID CDC42 PATHWAY | CDC42 signaling events |
0.4 | 2.2 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.4 | 7.1 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.3 | 1.4 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.3 | 2.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.3 | 0.6 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.3 | 18.4 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.3 | 10.3 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.3 | 0.6 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.3 | 2.8 | PID MYC PATHWAY | C-MYC pathway |
0.3 | 1.6 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.3 | 2.8 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.3 | 6.9 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.3 | 3.0 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.3 | 0.9 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.3 | 0.9 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.3 | 9.2 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.3 | 1.8 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.3 | 0.6 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.3 | 1.5 | PID ATR PATHWAY | ATR signaling pathway |
0.3 | 2.3 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.3 | 2.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.3 | 1.4 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.3 | 6.8 | PID E2F PATHWAY | E2F transcription factor network |
0.3 | 2.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.3 | 2.1 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.3 | 0.3 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.3 | 1.8 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.3 | 33.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.3 | 3.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.3 | 0.8 | PID BARD1 PATHWAY | BARD1 signaling events |
0.2 | 1.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.2 | 0.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 3.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 4.2 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.2 | 2.3 | NABA COLLAGENS | Genes encoding collagen proteins |
0.2 | 2.3 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.2 | 1.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 1.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.2 | 1.8 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 0.2 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.2 | 0.9 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 0.2 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.2 | 1.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.2 | 2.8 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.2 | 0.5 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.2 | 1.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 0.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 0.8 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 22.3 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 2.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 1.2 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 0.4 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.5 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 1.0 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 0.1 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 0.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.8 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 0.2 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 1.0 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 0.1 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 0.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.3 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 0.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 0.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.5 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.7 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.9 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.2 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.0 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.0 | ST G ALPHA I PATHWAY | G alpha i Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.7 | 33.3 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
5.7 | 152.9 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
5.3 | 5.3 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
5.2 | 41.9 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
4.5 | 63.6 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
2.9 | 83.1 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
2.9 | 51.3 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
2.8 | 33.6 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
2.8 | 22.1 | REACTOME OPSINS | Genes involved in Opsins |
2.5 | 69.0 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
2.4 | 43.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
2.4 | 25.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
2.3 | 25.1 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
2.2 | 34.4 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
2.2 | 6.5 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
2.0 | 95.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
2.0 | 25.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
2.0 | 76.1 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
1.9 | 21.3 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
1.9 | 17.1 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
1.8 | 16.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
1.7 | 38.3 | REACTOME AMYLOIDS | Genes involved in Amyloids |
1.7 | 10.3 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
1.7 | 13.7 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
1.7 | 18.8 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
1.6 | 29.3 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
1.5 | 22.6 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
1.5 | 16.2 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
1.4 | 14.3 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
1.4 | 42.3 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
1.4 | 22.4 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
1.4 | 1.4 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
1.4 | 12.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
1.3 | 5.3 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
1.3 | 17.1 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
1.3 | 35.2 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
1.3 | 13.0 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
1.3 | 14.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
1.3 | 35.2 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
1.2 | 8.6 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
1.2 | 2.4 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
1.2 | 9.2 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
1.1 | 8.0 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
1.1 | 13.7 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
1.1 | 1.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
1.1 | 10.9 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
1.1 | 9.5 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
1.0 | 14.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
1.0 | 1.0 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
1.0 | 4.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
1.0 | 7.2 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
1.0 | 25.5 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
1.0 | 3.0 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
1.0 | 1.0 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
1.0 | 9.9 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.9 | 10.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.9 | 34.0 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.9 | 18.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.9 | 13.8 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.9 | 10.1 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.9 | 16.5 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.9 | 12.7 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.9 | 8.1 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.9 | 8.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.9 | 4.5 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.9 | 6.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.9 | 5.3 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.9 | 18.9 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.9 | 4.3 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.9 | 16.2 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.8 | 15.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.8 | 7.5 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.8 | 13.9 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.8 | 15.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.8 | 65.1 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.8 | 8.7 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.8 | 3.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.8 | 7.8 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.8 | 1.5 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.8 | 6.2 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.8 | 0.8 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.8 | 13.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.7 | 4.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.7 | 2.2 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.7 | 4.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.7 | 8.0 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.7 | 7.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.7 | 10.8 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.7 | 45.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.7 | 5.0 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.7 | 8.5 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.7 | 66.4 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.7 | 4.9 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.7 | 2.8 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.7 | 18.8 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.7 | 24.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.7 | 2.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.7 | 5.5 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.7 | 8.8 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.6 | 10.3 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.6 | 4.5 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.6 | 4.5 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.6 | 33.6 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.6 | 11.1 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.6 | 6.1 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.6 | 15.6 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.6 | 18.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.6 | 4.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.6 | 1.2 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.6 | 4.7 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.6 | 9.8 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.6 | 15.9 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.6 | 1.7 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.6 | 12.3 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.6 | 17.8 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.6 | 11.1 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.5 | 0.5 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.5 | 2.7 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.5 | 2.7 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.5 | 6.2 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.5 | 9.7 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.5 | 6.1 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.5 | 8.1 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.5 | 10.1 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.5 | 3.5 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.5 | 3.0 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.5 | 2.0 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.5 | 19.2 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.5 | 26.0 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.5 | 4.9 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.5 | 1.0 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.5 | 1.0 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.5 | 4.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.5 | 20.3 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.5 | 5.1 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.5 | 3.2 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.5 | 6.0 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.5 | 27.8 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.5 | 1.8 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.4 | 2.2 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.4 | 1.3 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.4 | 1.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.4 | 1.3 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.4 | 5.8 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.4 | 72.7 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.4 | 1.2 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.4 | 8.5 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.4 | 4.5 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.4 | 3.2 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.4 | 8.3 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.4 | 7.4 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.4 | 12.5 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.4 | 7.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.4 | 10.7 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.4 | 5.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.4 | 21.6 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.4 | 4.8 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.4 | 3.2 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.4 | 5.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.4 | 1.4 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.4 | 5.3 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.3 | 9.8 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.3 | 2.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.3 | 33.6 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.3 | 5.0 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.3 | 2.7 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.3 | 4.9 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.3 | 7.5 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.3 | 1.6 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.3 | 0.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.3 | 0.6 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.3 | 1.9 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.3 | 45.2 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.3 | 3.0 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.3 | 4.8 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.3 | 5.7 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.3 | 3.2 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.3 | 2.6 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.3 | 7.7 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.3 | 4.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.3 | 4.4 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.3 | 3.8 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
0.3 | 3.0 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.3 | 23.7 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.3 | 6.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.3 | 3.1 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.3 | 1.8 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.3 | 7.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.3 | 6.1 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.3 | 2.8 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.2 | 2.2 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.2 | 1.7 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.2 | 2.6 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.2 | 1.9 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 2.0 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.2 | 2.0 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.2 | 1.8 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.2 | 1.5 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.2 | 0.4 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.2 | 3.4 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.2 | 1.8 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.2 | 3.0 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.2 | 7.3 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.2 | 0.5 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.2 | 3.7 | REACTOME PHOSPHOLIPID METABOLISM | Genes involved in Phospholipid metabolism |
0.2 | 0.8 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.2 | 0.7 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 0.6 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 2.9 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 1.9 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 5.3 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 5.5 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 1.1 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 0.4 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 0.8 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 0.5 | REACTOME DEFENSINS | Genes involved in Defensins |
0.1 | 1.5 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 0.7 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 0.7 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 0.5 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 0.2 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 0.4 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 0.2 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 0.2 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 1.0 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 1.5 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.1 | 0.1 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 0.1 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 0.8 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 0.3 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.1 | 0.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 0.1 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.1 | 0.8 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 0.8 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.1 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 0.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.6 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.0 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.5 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.0 | 0.1 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 0.1 | REACTOME PLATELET ACTIVATION SIGNALING AND AGGREGATION | Genes involved in Platelet activation, signaling and aggregation |
0.0 | 0.2 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 0.0 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 0.1 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.0 | 0.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.2 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.0 | 0.7 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.0 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |